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ABSTRACT 
 
Kimberly Kimiko Cobb  
North Carolina Metabolic Newborn Screening: Abnormal Screen Follow-up, 
Physician Knowledge & Risk for Transient Neonatal Tyrosinemia 
(Under the direction of Dr. Anita Farel) 
 
Newborn screening for inborn errors of metabolism (IEM) can help prevent or 
reduce mortality and morbidity through timely identification and subsequent 
treatment. North Carolina (NC) uses tandem mass spectrometry to screen newborns 
for over 25 IEM. This dissertation is divided into three parts. The first part examined 
follow-up procedures and compliance in submitting a repeat screen among NC 
newborns with a borderline abnormal initial newborn screening result. Data was 
drawn from linking newborn screening records with birth certificate, census and 
health professions data. No repeat screen was submitted for approximately 9% of 
these infants. Using logistic regression analysis adjusted for clustering, infants who 
were Hispanic, black, living in a neighborhood with a low socio-economic index, and 
whose families did not receive a sent notification letter were less likely to have a 
repeat screen submitted. The second part surveyed pediatricians of the NC Pediatric 
Society to explore pediatricians’ knowledge of NC newborn screening policies, their 
clinical protocol for handling results and their personal beliefs about the utility of 
newborn screening. About half of participants ranked themselves in the lower ranges 
of level of knowledge and comfort in communicating screening results. Only 57% of 
pediatricians correctly answered over half of the questions relating to newborn 
iv 
screening and state policies. Among those in clinical practice, 15% of pediatricians 
assumed that results were normal when they had not received a screening result 
and 32% did not provide families with normal screening results. The third part 
examined risk factors for transient neonatal tyrosinemia (TNT), abnormal elevations 
in tyrosine during the neonatal period that resolve in time. Using logistic regression 
analysis, infants who were premature, small-for-gestational-age, breast-fed or 
Hispanic were found to be at higher risk for TNT. Overall, these findings suggest 
that: 1-follow-up strategies need to address ways to improve rates of repeat screen 
submission, 2- further education is needed for pediatricians about newborn 
screening and its related policies, and 3- the number of false positive screens for 
inborn errors of tyrosine metabolism may be reduced by the consideration of 
gestational age, type of feeding and ethnic group. 
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CHAPTER 1 
 
INTRODUCTION 
 
Background 
Inborn Errors of Metabolism1
Inborn errors of metabolism (IEM) are caused by genetic mutations that 
interrupt some aspect of a metabolic pathway. Typically, a pathway enzyme, 
responsible for the breakdown of certain amino, organic or fatty acids, is missing or 
has lower than normal activity which causes an abnormal buildup of an intermediate 
metabolite, with associated toxic effects (1). Symptoms of an IEM can include 
metabolic decompensation, poor growth, behavioral difficulties, neurological 
problems, mental retardation and/or death. For example, in maple syrup urine 
disorder (MSUD), branched-chain-L-ketoacid dehydrogenase (BCKAD), an enzyme 
complex that breaks down the amino acids leucine, isoleucine and valine, does not 
function properly, leading to a build-up of these three amino acids (2). In untreated 
 
1Inborn errors of metabolism screened for in North Carolina include 2,4-Dienoyl-CoA Reductase 
Deficiency, 2-Methylbutyryl-CoA Dehydrogenase Deficiency, 3-Hydroxyl-3-Methylglutaryl-CoA Lyase 
Deficiency, 3-Ketothiolase Deficiency, e-Methylcrotonyl-CoA Carboxylase Deficiency, 5-
Oxoprolinuria, Arginiemia, Argininosuccinic Aciduria, Carnitine/Acylcarnitine Translocase deficiency, 
Carnitine Palmitoyl Transferase Deficiency Type II, Citrullinemia, Galactosemia, Glutaric Acidemia 
Type I & II, Homocystinuria, Hyperammonemia/ Hyperornithinemia/ Homocitrullinuria Syndrome, 
Hypermethionemia, Isobutyrl-CoA Dehydrogenase Deficiency, Isovalaric Acidemia, Long-Chain Acyl-
CoA Dehydrogenase Deficiency, Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency, Maple 
Syrup Urine Disease, Medium Chain Acyl-CoA Dehydrogenase Deficiency, Methylmalonic Aciduria, 
Mitochondrial Acetoacetyl-CoA Thiolase Deficiency, Multiple CoA Carboxylase deficiency, Nonketotic 
Hyperglycinemia, Phenylketonuria, Propionic Aciduria, Short-Chain Acyl-CoA Dehydrogenase, 
Tyrosinemia Type I & II, and Very-Long Chain Acyl-CoA Dehydrogenase Deficiency 
2children, the intermediates of incomplete amino acid breakdown accumulate and 
cause a maple syrup odor in the urine.  These intermediates can lead to metabolic 
acidosis, which may result in progressive neurologic dysfunction, loss of reflexes, 
alternating hypotonia and hypertonia and irregular respiration as well as seizures 
and death in severe cases (2). However, IEM can be treated through medications 
and/or strict dietary modifications that limit the offending metabolites and prevent 
accumulation of toxic intermediates. Since early diagnosis and initiation of treatment 
can limit morbidity and prevent mortality, these disorders are an appropriate focus 
for mass screening in newborns. While individually, metabolic disorders are rare, in 
combination they represent a significant population. In the U.S., newborn screening 
identifies approximately 3000 new cases each year (3), a frequency equal to that of 
juvenile onset diabetes mellitus (4).  
 
Newborn Screening
In the United States, over 4 million infants are screened each year for 
congenital disorders as part of state mandated newborn screening programs (5, 6). 
Newborn screening is a cost-effective public health program to prevent or reduce 
mortality, morbidity and disability through early and timely identification and 
subsequent treatment (7). It is a simple process, requiring a few small blood spots, 
taken from the infant’s heel, placed on filter paper, dried and mailed to the newborn 
screening laboratory. 
The idea of newborn screening began from work by Dr. Robert Guthrie who 
developed a screening test for PKU in the early 1960s. Because health 
3professionals had not uniformly adopted screening practices despite demonstrations 
of the feasibility of mass screening, grassroots lobbying was utilized and led to 
legislation mandating PKU screening in most states by the late ‘60s, followed by 
federal recommendations in 1976 (8). Improvements in technology, like tandem 
mass spectrometry (MS/MS), has increased the ability to test for many more 
disorders (9). So, although only two disorders, PKU and hyperthyroidism, have been 
routinely screened nationally, many states are beginning to expand the number of 
disorders for which they screen, some to over twenty (10). While this study focused 
on screening for IEM, many states have also begun to include other disorders2 that 
benefit from detection in infancy such as hearing impairment, sickle cell anemia or 
cystic fibrosis. 
 
Tandem Mass Spectrometry (MS/MS)
Since 1997, the Newborn Screening Program in North Carolina has utilized 
MS/MS to analyze newborn samples for amino, organic and fatty acid disorders 
(IEM). MS/MS technology for newborn screening, developed by North Carolina at 
the DUKE University Mass Spectrometry Facility (11), has revolutionized newborn 
screening. MS/MS can rapidly detect over 25 metabolic disorders in a single assay 
with the same overall cost as previous methods, which were limited to a few 
disorders (5). The MS/MS process is less laborious and time consuming, takes only 
minutes, and has an improved sensitivity and specificity over previous methods such 
as paper and thin layer chromatography (5, 12). 
 
2Other disorders screened for in North Carolina include Congenital Adrenal Hyperplasia, congenital 
Hypothyroidism, Sickle Cell Disease and Hemoglobinopathies, and hearing impairment. 
4In North Carolina, MS/MS screening detects one infant with a confirmed 
metabolic disorder for every 4,400 births (13). In 2002, a study by Schoen and 
colleagues (14) that analyzed the costs and benefits of screening 32,000 infants in 
Northern California found that MS/MS screening had comparable costs per quality-
adjusted life year saved as other screening programs with a cost of $5827 per 
quality adjusted life year saved. A lifetime cost savings in treatment ranging from 
$4.86 to $5.98 per test performed was shown from the early diagnosis associated 
with newborn MS/MS screening (14). A review of clinical and cost effectiveness 
found a mean incremental gain of 59 life years in just the screening for PKU and 
medium-chain acyl-coenzyme-A dehydrogenase deficiency (MCADD) (15). 
Currently, only a handful of states have fully implemented MS/MS programs 
(5). While the cost of reagents and peripheral equipment is relatively inexpensive, 
the initial cost of instrumentation is a limiting factor for many states (16). However, 
more states are realizing the benefits of this new technology and are turning to 
states already using MS/MS for guidance. Thus, examining salient public health 
issues that have arisen in the North Carolina Newborn Screening Program is timely 
and important for not only improving North Carolina’s program, but also for the 
development of new programs in other states. 
 
Significance
While North Carolina was the first state to use MS/MS for state-wide newborn 
screening, their current procedures for abnormal screens have not been thoroughly 
investigated. Evaluating the ability of current procedures to respond to abnormal 
5screening results has important policy implications for ensuring that infants are not 
lost to follow-up and to prevent or reduce morbidities and mortalities associated with 
delayed treatment. This study examined the frequency and predictors in lack of 
repeat screen submission among infants with an initial abnormal newborn screen. 
Physicians play a crucial role in the newborn screening system, especially in follow-
up for abnormal screens and communication with families. This study explored what 
pediatricians know about newborn screening in North Carolina, their beliefs and their 
clinical practices. Knowing more about what physicians understand and do with 
newborn screening results can help determine further educational needs which may 
ensure that partners in the screening program are aware of their role and ensure the 
system is working efficiently as possible to prevent missing affected infants and 
improve communication of results to families. In addition, understanding more about 
infants characteristics that are associated with high false-positive screens such as 
tyrosine, can provide markers to limit who is considered positive and thus limit the 
number of repeat testing, reduce costs and reduce family stress. To better 
understand this disorder and its implications on newborn screening, this study 
looked at risk factors for transient neonatal tyrosinemia. Overall, the results of this 
study will contribute to understanding of current issues in newborn screening and 
help to find ways to improve the effectiveness and efficiency of the North Carolina 
Newborn Screening Program. 
6Specific Aims 
Aim 1: Evaluate the procedures of the North Carolina Newborn Screening Program 
for abnormal screen follow-up among infants who have abnormal initial newborn 
screens, determine the rate of no repeat screen submission, describe the 
characteristics and trends among infants in the repeat and no repeat screening 
groups, and examine predictors for loss to follow-up. 
 
1. What percent of infants, who have an abnormal initial newborn screen, 
receive a second (repeat) screen? 
 
2. What procedures to contact families occur prior to an infant receiving or 
not receiving a repeat screen? 
 
3. What are the socio-demographic characteristics of infants for whom a 
repeat screen was and was not submitted and have there been changes 
over time in these characteristics? 
 
4. Are individual- and community-level factors associated with not submitting 
a repeat screen? 
• Individual-Level Factors 
o Infant characteristic (race / ethnicity)  
o Parental characteristics (education, age, parity) 
7o Family response to notification letter of test results/ 
repeat request 
o Distance between family residence and infant’s 
primary care physician 
 
• Community-Level Factors  
o County-level pediatricians per 10,000 population 
o Community (census tract) socio-economic ranking  
o Metropolitan or Non-Metropolitan County 
 
Aim 2: Evaluate pediatricians’ knowledge of the purpose and procedures for 
newborn screening in North Carolina and assess current clinic practices for 
adherence to state recommended procedures. 
 
1. What is the level of knowledge of pediatric primary care physicians 
concerning the purpose of newborn screening and the current state-
recommended policies for newborn screening? 
 
2. How do pediatric primary care physicians relay newborn screening results 
to families and arrange for repeat screens for abnormal initial screens? 
 
83. How does the pediatric primary care physician’s knowledge of newborn 
screening relate to their clinical practices? 
 
Aim 3: Determine risk factors for transient neonatal tyrosinemia.  
 
1. Is type of feeding (breast, formula, or total parenteral nutrition) associated 
with an increased risk for having transient elevations in newborn screening 
tyrosine levels compared to infants with no abnormal metabolites on their 
newborn screen? 
 
2. Is race or ethnicity associated with an increased risk for having transient 
elevations in newborn screening tyrosine levels compared to infants with 
no abnormal metabolites on their newborn screen? 
 
3. Is size for gestational age, associated with an increased risk for having 
transient elevations in newborn screening tyrosine levels compared to 
infants with no abnormal metabolites on their newborn screen? 
 
4. Does gestational age modify the effect of type of feeding, race/ethnicity 
and/or size for gestational age on the risk for transient elevations in 
newborn screening tyrosine levels? 
 
9References 
 
1. Carreiro-Lewandowski E. Newborn screening: an overview. Clinical 
Laboratory Science 2002;15:229-238. 
 
2. Shils M, Olson J, Shike M, Ross A. Modern Nutrition in Health and Disease. 
Baltimore, MD: Lippincott Williams & Wilkins, 1999. 
 
3. Council of Regional Networks for Genetic Services, Genetic Services Branch/ 
MCHB/ HRSA. Integrating Genetic Services Into Managed Care. Washington, 
DC, 1997:1-79. 
 
4. Novello A. Inherited metabolic diseases: Collaborating for the health of all 
children. Biochemical Medicine and Metabolic Biology 1993;49:277-284. 
 
5. Goodwin G, Msall M, Vohr B, Rubin L, Padbury J. Newborn screening: an 
overview with an update recent advances. Current Problems in Pediatric and 
Adolescent Health care 2002;32:144-172. 
 
6. Center for Disease Control. Vital Statistics. National Vital Statistics Reports 
2002;50:40. 
 
7. American Academy Pediatrics Newborn Screening Task Force. Newborn 
screening: a blueprint for the future. Pediatrics 2000;106:386-427. 
 
8. American Medical Association. Newborn screening: challenges for the coming 
decade: Council of Scientific Affairs, 2002:1-8. 
 
9. Sweetman L. Newborn screening by tandem mass spectrometry. Clinical 
Chemistry 1996;42:345-346. 
 
10. Albers S, Waisbren S, Ampola M, et al. New England Consortium: a model for 
medical evaluation of expanded newborn screening with tandem mass 
spectrometry. Journal of Inherited Metabolic Disorders 2001;24:303-304. 
 
11. Chance D, Millington D, Terada N, Kahler S, Roe C, Hofman L. Rapid 
diagnosis of phenylketonuria by quantitative analysis for phenylalanine and 
tyrosine in neonatal blood spots by tandem mass spectrometry. Clinical 
Chemistry 1993;39:66-71. 
 
12. Naylor E, Chance D. Automated tandem mass spectrometry for mass 
newborn screening for disorders in fatty acid, organic acid, and amino acid 
metabolism. Journal of Children and Neurology 1999;14:S4-S8. 
 
10 
13. Frazier D, Millington D, McCandless S, Koeberl D, Chaing S, Muenzer J. The 
tandem mass spectrometry newborn screening experience in North Carolina: 
1997-2005. Journal of Inherited Metabolic Disease (in press) 2006. 
 
14. Shoen E, Baker J, Colby C, To T. Cost-benefit analysis of universal tandem 
mass spectrometry for newborn screening. Pediatrics 2002;110:781-786.  
 
15. Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. Clinical effectiveness 
and cost-effectiveness of neonatal screening for inborn errors of metabolism 
using tandem mass spectrometry: a systematic review. Health Technology 
Assessment 2004;8:1-121. 
 
16. Chance D, Theodore T, Naylor E. Use of tandem mass spectrometry for 
multianalyte screening of dried specimens from newborns. Clinical Chemistry 
2003;49:1797-1817. 
 
CHAPTER 2 
 
DESCRIPTION OF DATA SOURCES, DATA COLLECTION, AND STUDY 
VARIABLES 
 
Secondary Data Sources, Collection and Variables 
 The following secondary data sources were used to provide data for the 
studies in Chapter 3 (Tandem Mass Spectrometry (MS/MS) Newborn Screening in 
North Carolina: Follow-up of Abnormal Screens) and Chapter 5 (Risk Factors for 
Transient Elevation of Tyrosine in Newborns). 
 
Secondary Data Sources: 
Laboratory Information Management System (LIMS)
The main data source was newborn screening data which was available from 
the Laboratory Information Management System (LIMS) at the North Carolina State 
Laboratory of Public Health (SLPH) in Raleigh, North Carolina. Since all North 
Carolina newborn are mandated to be screened, approximately 120,000 specimens 
and accompanying information are entered into the database each year. The 
specimen submitter, usually the birth hospital, completes an informational card that 
is attached the filter paper containing the screening specimen. This data, which are 
entered into the LIMS database, contains information on the mother (name, address, 
social security number, and phone number) and infant (name, multiple births, birth 
date/time, race, ethnicity, gender, birth weight, type of feeding, transfusion date/time, 
12 
specimen date/time, and physician).  The LIMS database also contains information 
provided by the SLPH such as initial and repeat laboratory results, laboratory 
identification number and an event log that describes the follow-up of abnormal 
screens (letters or calls to physicians, letters to families, and response to these 
contacts).  
 
Birth Certificate Data
The North Carolina State Center for Health Statistics (SCHS) (1), also located 
in Raleigh, maintains the database of birth certificates. Birth certificate data includes 
specifics of the birth as well as demographic and health information on the infant and 
parents. For this study, information on maternal age, educational level, race/ethnicity 
and parity were used.  
 
Health Professions Data System
The Health Professions Data System (2) was created by the Cecil G. Sheps 
Center for Health Services Research to collect and disseminate timely and reliable 
data on selected licensed health professionals in North Carolina. The restricted 
access database contains detailed information on health care professionals 
practicing in North Carolina. The public use database contains state, regional and 
county level information on North Carolina such as population demographics, 
metropolitan versus non-metropolitan designation and total number of physicians, 
specialty physicians and other health care professionals. Since the study period was 
from 2000-2003, data from 2002, the middle year, was used. This study used the 
13 
public access database to provide county-level information on the number of 
pediatricians per 10,000 residents and metropolitan or non-metropolitan status.  
 
North Carolina Census Data
U.S. census data provides information on all individuals and households 
which are grouped into various levels of aggregation. Since individual level 
economic data was unavailable from the previous data sources, this study used 
these area-based measurements from the census data to create a community socio-
economic index. Census data tables that were abstracted are described in Table 
2.1. For this study, data on North Carolina by census tracts were abstracted from the 
Geolytics Census CD 2000 Summary File 3 Long Form available from Davis Library 
at the University of North Carolina at Chapel Hill. Census tracts are small statistical 
subdivisions that are designed to have relatively homogenous demographic 
characteristics (3). Tracts average around 4,000 people. Census blocks, smaller 
groups within tracts (~1000 people) were not selected because these areas were 
likely too small to provide results of interest. Studies have found both blocks and 
tracts provide similar results and are able to detect larger effects than zip codes (4). 
Zip codes average around 30,000 people and are administrative units for delivery of 
mail. In a validation study, Krieger and colleagues (5) found that census-level and 
individual-level socioeconomic measures were similarly associated with health 
outcomes.  
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Secondary Data Collection: 
The SLPH abstracted the desired study data from the LIMS database and 
enabled the State Center for Health Statistics to download this newborn screening 
study data via the SLPH password-protected website. Staff at the State Center for 
Health Statistics linked the newborn screening data to their birth certificate data. 
Over 99% of newborn screening records were successfully matched with birth 
certificate data. Data were provided to the author with personal identifiers such as 
infant’s name, mother’s name, mother’s phone number and mother’ social security 
number removed. Information on the follow-up steps by SLPH from the event log for 
each infant was only available on the computers at the SLPH. Using the LIMS 
identification number, the newborn screening record was accessed to provide a 
second verification of whether an infant had a repeat screen and to record 
information from the event log on follow-up. This information was abstracted by hand 
from the LIMS database by the author. At this point, finding infants who were not 
followed up was not a concern since the study period ended in 2003 and by this time 
all infants with a metabolic disorder would most likely have been diagnosed 
clinically.  
To obtain geographic information on the study population, the author provided 
a statistical consultant at the Cecil G. Sheps Center for Health Services Research 
with the addresses for infants and their health care providers without other personal 
identifiers or other study information. Geographic Information System (GIS) software 
was used to find indicator codes for census data and corresponding latitude and 
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longitude for each address. SAS software was used to calculate crow-fly miles 
between the infant and their health care provider. 
North Carolina census data from the 2000 US Census were abstracted by the 
author from the Geolytics Census CD 2000 Summary File 3 Long Form. Census 
tract were then linked to each infant based on their address and corresponding 
census tract data with greater than 99.5% success. Public use data from the North 
Carolina Health Professions Data System were abstracted by hand from the data 
system website and entered into STATA. This county-level information was linked to 
each infant based on their county of residence with 100% success. 
 
Study Variable Created from Secondary Data Sources: 
In preliminary analyses, variables were considered in various forms as 
continuous or categorical. Variables with well-established categories used these 
recognized cut-points. Other variables were examined to determine the most 
appropriate representation using visual tools such as graphs or statistical tests of 
crude associations.  
 
• Repeat Screen Status 
After an initial abnormal newborn screen, infants either had a repeat screen 
or did not have a repeat screening record in the LIMS database as 
represented by this dichotomous variable.  
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• Tyrosine Screen Status  
This dichotomous variable was described as normal or abnormal based on an 
infants initial newborn screening result for tyrosine. An abnormal result was 
considered an elevation in tyrosine > 300 mg/dl. 
 
• Gender  
Gender was represented as a dichotomous variable, male or female as 
indicated on the newborn screening card. If this information was missing, 
gender was taken from birth certificate data.  
 
• Race/ Ethnicity 
Non-Hispanic White, Non-Hispanic Black, Non-Hispanic Other and Hispanic 
were the categories used to describe an infant’s race/ethnicity. The infants 
were classified as Hispanic if Hispanic/Latino Origin was selected as their 
ethnicity on their screening card regardless of race. Infants with Non-Hispanic 
selected for ethnicity were divided into Non-Hispanic White, Non-Hispanic 
Black and Non-Hispanic Other. Because of small sample size, Non-Hispanic 
American Indians, Non-Hispanic Asians, Non-Hispanic Hawaiian/Other 
Pacific Islanders were included in the same Non-Hispanic Other category as 
those who marked Unknown or multiple selections for the infant’s race. If 
ethnicity or race was missing from their newborn screening card (< 2% of 
infants), mother’s race and/or ethnicity from the newborn’s birth certificate 
was used.   
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• Birth Weight 
Birth weight was recorded as a continuous variable in grams.  
 
• Clinical Estimation of Gestation 
Clinical estimation of gestation was recorded as a continuous variable in 
weeks from birth certificate data. The established categories of preterm (< 37 
weeks) and term (H 37 weeks) were used. 
• Small-for-Gestational-Age (SGA) 
SGA was defined as infants whose birthweight was below the 10th percentile 
for similar infants of the same gestational age. For Hispanic infants, SGA was 
calculated using the algorithm created by Overpeck and colleagues (6) which 
required information on parity, infant’s gender, birth weight and gestational 
age. For Non-Hispanic infants, SGA was calculated using the algorithm 
created by Zhang and colleagues (7) which required information on parity, 
infant’s gender, birth weight, gestational age and race. For the latter 
algorithm, race-specific information on Asian, American Indian and 
other/mixed race were not available so the algorithm for white infants was 
utilized since the mean birth weight of these term infants were most similar to 
those of the white infants. 
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• Infant Age at Screen Collection 
Infant age at newborn screen collection was indicated on the screening card 
in hours. Since the recommended age at collection for North Carolina is 24-72 
hours, categories of < 24 hours, 24-72 hours and > 72 hours were considered 
and as no significant differences between the <24hour and 24-72 hour group 
was found, infant age at specimen collection was described as either T 72 
hours or > 72 hours. 
 
• Multiple Birth 
Multiplicity was dichotomized as either a singleton or a multiple birth as noted 
on the newborn screening record. 
 
• Feeding Type 
The categories of feeding were breast feeding, formula feeding, total 
parenteral nutrition (TPN) feeding and combination feeding. If the feeding 
type was designated as solely breastmilk, formula or TPN on the newborn 
screening card, infants were considered to be exclusively fed by that method 
of feeding at the time of newborn screening. If more than one type of feeding 
was selected, then infants were considered to have combination feeding.   
• Maternal Education 
Total years of maternal education were available from birth certificate data. 
As it is typically represented in the literature, maternal education was 
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categorized as less than high school, high school graduate or greater than 
high school education. 
 
• Maternal Age 
Maternal age was listed in years from birth certificate data. A continuous 
variable centered at 26 years, the mean maternal age, was first considered. 
Age categories of teen (< 20 year), adult (20-34 years) and later adult (H 35 
years) better represented the data and aided in data interpretation. Because 
no statistical difference was seen between adult and later adult, the variable 
was simplified into a dichotomous variable of teen mom (< 20 years) and 
adult mom (H 20 years). 
 
• Parity:
Parity or the number of living children in the family was recorded as a 
continuous variable from birth certificate data. Parity was dichotomized as 
primipara or multipara.   
 
• Parental Letter 
From follow-up records in the newborn screening database, the parent 
notification letter was considered “not received” if the certified (now called 
confirmed receipt) letter failed to be delivered, “received” if the letter was sent 
and received or “not necessary” if a repeat screen was received within 14 
days.  
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• Physician Distance:
Using addresses provided on the newborn screening card the distance from 
each infant’s residence to their indicated primary health care physician was 
calculated in miles. Distance to physician was examined as both a continuous 
and categorical variable. Graphical representation of the association of repeat 
screen and the continuous distance were examined and cut-points of 25 and 
50 miles were considered. Based on further crude analysis, distance to 
physician was categorized as T 25 miles or >25 miles.  
 
• County Primary Care Physician (PCP) Ratio 
From the Health Professions Data System, this ratio represents for each 
county, the number of pediatricians per 10,000 residents. Pediatricians were 
physicians who self-reported a primary specialty of pediatrics. In order to 
create a three level categorical variable, cut-points for these categories were 
determined by graphically representing this data, and observing where natural 
grouping occurred. The county PCP ratio was thus divided into three 
categories, low (< 5 PCP per 10,000), average (5-9 PCP per 10,000) and high 
(H 10 PCP per 10,000). 
• County Type 
The county metropolitan status was indicated in the Health Professions Data 
System as either metropolitan or non-metropolitan. This designation is 
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determined by the federal government, based on population and commuting 
data from the census.  
 
• Community SES Index 
Since information on parental income was not available from these secondary 
data sources, family-level socioeconomic status (SES) could not be 
established. As an alternative, an area-based socioeconomic measure was 
created using 2000 census tract data for North Carolina. Variables were 
created from census tables (Table 2.1) to indicate occupational class (percent 
working class, professional class and unemployed), income (percent low 
income and percent high income), poverty (percent below poverty line), 
education (percent low and high education), stability (percent movement of 
houses and counties over five years) and other demographics (percent in 
urban and rural areas). The selection of these variables was based on studies 
by Krieger and colleagues (4, 5) which discussed choosing area based 
socioeconomic measures to monitor social inequalities and validation of 
census-based methodology. Principal components analysis was used to 
create a summary measure of SES by analyzing the variables created from 
census data defined in Table 2.2. From the principal component analysis 
score, quartiles were created to rank each census tract in four levels of low to 
high SES. 
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Materials and Primary Data Collection 
The following description describes the materials and primary data collection 
for the study in Chapter 4 (Metabolic Newborn Screening Knowledge and Clinical 
Practices: Survey of North Carolina Pediatric Society Physicians).  
 
Materials: 
A 10-15 minute self-administered anonymous paper survey was designed to 
assess pediatrician’s knowledge of newborn screening and their current newborn 
screening practices (See Appendix 1). The survey combined open-ended and 
multiple choice questions. The survey was designed by the author with the 
assistance of members of the North Carolina Newborn Screening Advisory Board 
and it was reviewed by two pediatricians experienced in survey design methods.  
Three pediatricians in the Department of Metabolism and Genetics at the University 
of North Carolina Hospital took part in the pre-test. Using feedback provided on the 
survey, the clarity, content and structure of questions were assessed and questions 
were restructured accordingly.  
Section A of the survey focused on the physician’s clinical practices. It had 
five general newborn screening experience questions (questions (Q) 1-3, 7&10), four 
actual clinical practice questions (Q4-6, 9) and one self-ranked understanding of 
newborn screening (Q8). The main purpose of this section was to determine how 
physicians incorporated newborn screening into their practices (Q4-6, 9). These four 
questions addressed what physicians do if they do not have a newborn screening 
report on a new infant patient (Q4), who contacts a family with a diagnostic abnormal 
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(Q5), whether parents are informed of a normal screen (Q6), and what is done to re-
screen an infant with an abnormal screen (Q9). The self-ranked comfort with 
newborn screening (Q8) provided an overall estimation of the physician’s perceived 
comfort in explaining newborn screening results to families. 
Knowledge of North Carolina newborn screening procedures was addressed 
in section B of the survey. There were seven questions on newborn screening 
procedures (Q11-17) and one question on self-ranked knowledge on the newborn 
screening policy/procedures (Q18). The questions examined knowledge about the 
age for initial newborn screening (Q11), newborn screening for early discharge 
(Q12), SLPH follow-up for abnormal screens (Q13), payment for confirmatory testing 
(Q14), goal of newborn screening (Q15), age restriction for newborn screening 
(Q16), and understanding of pre-symptomatic nature of screening (Q17). The self-
ranked knowledge (Q18) provided a comparison between perceived and actual 
knowledge about newborn screening. 
Section C explored the physician’s opinion on the application of newborn 
screening in the state and recommendations for information dissemination about 
newborn screening. The first question of section C examined if the physician agrees 
with the recommended purpose of newborn screening (Q19). Widespread screening 
is only recommended for disorders for which screening can detect disease before 
symptoms occur, for which the disorder can be diagnosed, treated and followed up, 
and for which there are clear benefits to the patient (8). The next question confirmed 
the ideas expressed in Q19, with practical applications of selecting disorders which 
they believe should be screened (Q20). The final question in section C (Q21) asked 
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for recommendations on how best to communicate information about newborn 
screening to physicians. 
The finals section, section D, of the survey asked basic demographic 
information about the participating physician such as gender, years in practice, type 
and location of practice. This section was used to characterize the survey 
participants and to compare with non-participant to determine if the survey 
participants were representative of North Carolina Pediatric Society (NCPS) meeting 
attendees. 
 
Data Collection Procedure: 
The NCPS (also known as The North Carolina Chapter of the American 
Academy of Pediatrics) represents over 1,200 pediatric physicians in the state. Its 
membership includes pediatricians or family practice physicians in private, 
academic, or subspecialty practices, as well as pediatric residents, medical students 
and allied health professionals. Eligible study participants included North Carolina 
physicians who attended one of the following three meetings of the North Carolina 
Pediatric Society (NCPS) in 2004:  the Spring Forum (March 2004), the Open Forum 
(April 2004) and the Annual Meeting (August 2004). 
The survey was administered at these three NCPS meetings as a self-
administered, and paper questionnaire. Surveys were placed on the seats for all 
conference participants prior to each meeting. At the beginning of each meeting, the 
author spoke briefly about the survey and requested participation of primary care 
physicians. The participants returned the completed survey by the close of each 
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meeting to the designated collection box as indicated orally and on the survey. A 
unique identification number was assigned to each survey to denote which meeting 
was attended. Answers from the survey were entered by the author into STATA v8 
for analysis.  
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Table 2.1 Description of Census Tables Abstracted from the 2000 United 
States Census with Examples of Included Information 
Table # Table Contents Examples of Information Included 
P1 Total Population Total population 
P5 Urban and Rural Urban, rural 
P24 Residence in 1995 for the Population 
5 Years and Over – State and County 
Level 
Same county in 1995, same house in 
1995 
P37 Sex by Educational Attainment for 
the Population 25 Years and Over 
Male/female: 11th grade, high school 
graduate, some college, master’s degree 
P43 Sex by Employment Status for the 
Population 16 Years and Over 
Male/female: employed, unemployed 
P50 Sex by Occupation for the Employed 
Civilian Population 16 Years and 
Over 
Male/female: management, professional 
and related occupations, service 
occupations 
P52 Household Income in 1999 Total, less than $10,000, $10,000 to 
$14,999, $200,000 or more 
P53 Median Household Income in 1999 Median household income in 1999 
P87 Poverty Status in 1999 by Age Income in 1999 below poverty level, 
income in 1999 at or above poverty level 
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Table 2.2 Definition of Selected Variables Created from 2000 United States 
Census Data Used to Create the Community-based Socio-economic Index 
Variable Definition 
Working Class Percent of persons employed predominantly in working 
class occupations using the following 5 of 7 census based 
occupational groups: service (except protective); sales and 
office; farming, fishing and forestry; construction, extraction 
and maintenance; production, transportation and material 
moving 
Professional Class Percent of persons employed predominantly in professional 
class occupations using the following 2 of 7 census based 
occupational groups: management, professional, and 
related; professional and related; protective services 
Unemployment Percent of persons age 16 and older in the labor force who 
are unemployed 
Median Household Income* Median household income in 1999 
Low Income Percent of households with <50% of US median income 
High Income Percent of households with income >400% of US median 
income 
Below Poverty Percent of persons below federally defined poverty line 
Low Education Percent of persons age 25 and older with less than a 12th 
grade education 
High Education Percent of persons age 25 and older with at least four years 
of college 
Urban Percent of persons who live in an urban designated area 
Rural Percent of persons who live in a rural designated area 
Household Movement Percent of persons who lived in a different house in 1995 
County Movement Percent of persons who lived in a different county in 1995 
*Median household income used to create low and high income variables, not included in PCA 
analysis. 
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CHAPTER 3 
 
TANDEM MASS SPECTROMETRY (MS/MS) NEWBORN SCREENING IN NORTH 
CAROLINA: FOLLOW-UP OF ABNORMAL SCREENS 
 
Abstract 
North Carolina uses tandem mass spectrometry (MS/MS) to screen newborns 
for over 25 inborn errors of metabolism. Screening results are categorized as 
normal, borderline abnormal or diagnostic abnormal. While infants with a diagnostic 
abnormal result are immediately referred for more specific confirmatory testing, 
infants with borderline abnormal results are requested to submit a repeat newborn 
screen. This study examined the compliance in submitting a repeat screen and the 
follow-up procedures that occurred for newborns born in North Carolina between 
January 1, 2000 and December 31, 2003 with a borderline abnormal newborn 
screening result. Data were collected from the North Carolina newborn screening 
database and linked to birth certificate and US census data. No repeat screen was 
submitted for approximately 9% of infants with borderline abnormal results. While 
there were no documented cases of inborn errors of metabolism missed in this 
group, infants with an initial borderline abnormal screen have a 2% risk of having an 
inborn error of metabolism. Among infants who had a repeat screen submitted, 58% 
had a repeat screen submitted within the desired time-frame of 14 days after 
physician notification and thus, a parental notification letter was necessary to prompt 
a repeat screen submission for many infants. This study also examined both 
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individual- and community-level risk factors to determine their effect on the 
submission of a repeat screen using logistic regression analysis adjusted for 
clustering by community. Hispanic infants (AOR 2.1, 95% CI 1.2, 3.8), Black infants 
(AOR 1.9, 95% CI 1.2, 3.1) and infants living in a neighborhood with low SES (AOR 
2.3, 95% CI 1.4, 4.0) were less likely to have a repeat screen submitted. Infants 
whose family did not receive the parental notification letter were also less likely to 
have a repeat screen submitted (AOR 1.6, 95% CI 1.1, 2.4), demonstrating the 
importance of this letter in addition to physician notification. Follow-up strategies that 
address the characteristics of these at-risk infants that make them vulnerable to loss 
to follow-up could further improve the efficiency of the collection and submission of 
an indicated repeat screen. 
 
Introduction 
In the United States, over 4 million infants are screened each year for inborn 
errors of metabolism (IEM) as part of state-mandated newborn screening programs 
(1, 2). IEM are caused by mutations in the enzymes responsible for the breakdown 
of certain amino acids, organic acids and fatty acids. If untreated, IEM cause 
metabolic decompensation, behavioral difficulties, poor growth, neurological 
problems, mental retardation and/or death (3). However, if treated in early infancy, 
these symptoms may be reduced or prevented, making them ideal for newborn 
screening. 
Since 1997, the Newborn Screening Program in North Carolina has utilized 
tandem mass spectrometry (MS/MS) to analyze newborn samples for abnormal 
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analytes indicating over 25 IEM. As mandated by state law (G.S. 130A-125), all 
infants born in North Carolina should have a newborn screen between 48-72 hours 
of age. Specimens are sent to the State Laboratory of Public Health for analysis. For 
infants with a normal screen, a report is sent to their primary care physicians (PCP) 
and birth hospital and no follow-up is necessary. For abnormal screens, North 
Carolina has a two-tiered system of cutoffs and follow-up for the diagnostic abnormal 
and borderline abnormal results (Figure 3.1). The upper (diagnostic) cutoff and 
prompts an immediate call to the PCP and referral for confirmatory testing. This 
extremely elevated screen is highly suggestive of a metabolic disorder with an 
average of 57% of these infants having an IEM diagnosis (4). The lower (borderline) 
cutoff prompts a report to the PCP and birth hospital with instructions to collect a 
repeat screen. It is the PCP’s responsibility to notify the family and obtain a repeat 
screen. However, if no repeat screen is received within two weeks, the state lab 
sends a letter by certified mail to the mother. After this point, no further attempts are 
made to follow-up with infants who have not had a repeat screen submitted.  
The success of newborn screening programs depends on the ability to 
diagnose and treat an infant early enough to prevent irreversible consequences of 
the disorder. A lack of repeat screen for an abnormal initial screen can impede the 
ability to diagnose an infant in a timely manner. Infants with an IEM who are not 
identified by newborn screening may not be diagnosed prior to symptoms, but 
instead diagnosed clinically. A study by Waisbren and colleagues (5), comparing  
infants diagnosed by newborn screening versus clinically, found that infants 
identified through newborn screening had better health outcomes and their parents 
32 
had a lower stress index rating. Clinically diagnosed infants began treatment a 
median of 4 months later, experienced 60% more symptoms at time of diagnosis, 
had more complications after diagnosis, were three times more likely to require 
additional interventions or special services and were more likely to have significant 
deficits in communication, daily living skills, socialization and motor skills (5). Thus, 
timely diagnosis is critical for optimal health outcomes. The American Academy of 
Pediatrics identified the assessment of follow-up and the enumeration of infants who 
are lost to follow-up as a priority (6). This study examined follow-up procedures for 
newborns with borderline abnormal newborn screens in North Carolina to determine 
the compliance in submitting a repeat screen. This study also explored both 
individual- and community-level risk factors that may affect the submission of a 
repeat screen for infants with an initial borderline abnormal screen. 
 
Methods 
Study Population 
 Identified from infants born and screened in North Carolina between January 
1, 2000 and December 31, 2003 (n=366,444), the study population consisted of 
infants who had a borderline abnormal result on their initial newborn screen 
submitted to the North Carolina State Laboratory of Public Health (n=2028). The 
case group (n=175) included the infants who did not have the indicated repeat 
screen submitted to the state lab. The control group (n=1853) included all infants 
who had a repeat screen submitted. The ratio of cases to controls was 1:10.5. 
Infants were excluded if death occurred within three months of birth.  
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Data Collection 
 Newborn screening data were abstracted from the Laboratory Information 
Management System (LIMS) database of the North Carolina Newborn Screening 
Program at the State Laboratory of Public Health. The LIMS database included 
information provided by the specimen submitter via a data card which was attached 
to the filter paper holding the screening specimen and containing infant 
demographics, medical information and maternal contact information, all initial and 
repeat screening results. This database also contained an event log describing any 
follow-up activities. Additional information about an infant’s gestational age and 
parental demographic information was obtained by the matching of the newborn 
screening data to birth certificate data. The North Carolina State Center for Health 
Statistics processed this matching and over 99% of newborn screening records were 
successfully matched with birth certificate data. Those that did not match were 
dropped from the study. Community-level information was gathered from the public 
use data of the 2000 US Census and the Cecil G. Sheps Center’s Health 
Professions Data System. Data on North Carolina by census tract was abstracted 
from the Geolytics Census CD 2000 Summary File 3 Long Form. Public use data 
from the North Carolina Health Professions Data System were used to provide the 
ratio of primary health care physicians (PCP) per 10,000 persons and 
metropolitan/non-metropolitan indication by county for 2002, the middle year of the 
study. Census tract and county information were then linked to each infant based on 
their address with greater than 99.5% success. Infants were excluded if community-
level data were not matched. 
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Study Variables 
The dependent variable was the presence or absence of a repeat screen 
recorded in the LIMS database. Gender, age at screen (hours), and race/ethnicity 
(Non-Hispanic White, Non-Hispanic Black and Non-Hispanic Other) were provided 
by the LIMS database as indicated on the newborn screening card. Because of 
small sample size, Non-Hispanic American Indians, Non-Hispanic Asians, Non-
Hispanic Hawaiian/Other Pacific Islanders were included as Non-Hispanic Other 
along with those infants who had Unknown or multiple selections marked for their 
race. If ethnicity or race was missing from their newborn screening card (< 2% of 
infants), mother’s race and/or ethnicity from the newborn’s birth certificate was used.  
Likewise, gender was taken from birth certificate information if missing in newborn 
screening data. From follow-up information in the LIMS database, the parental letter 
was considered “not received” if the letter was unable to be delivered, “received” if 
the letter was sent and received or “not necessary” if a repeat screen was received 
within 14 days. Gestational age (< 37 weeks, H 37 weeks), maternal age (< 20 
years, H 20 years), maternal education (< high school, high school graduate, > high 
school) and parity (primipara, multipara) were provide by birth certificate data as 
continuous variables and created into categorical variables. 
 With the assistance of the Cecil G. Sheps Center for Health Services 
Research, Geographic Information System (GIS) software was used to provide 
geographic information. SAS software was used to calculate crow-fly miles between 
the infant and their health care provider to create the distance to physician variable 
(T 25 miles or >25 miles).  The county PCP ratio from the Health Professions 
35 
Database was divided into three categories, low (< 5 PCP per 10,000), average (5-9 
PCP per 10,000) and high (H 10 PCP per 10,000). The county metropolitan status 
was indicated in the Health Professions Database as either metropolitan or non-
metropolitan. This designation was determined by the federal government, and was 
based on population and commuting data from the census.  
 Since information on parental income was not available from these secondary 
data sources, family-level socioeconomic status (SES) could not be established. As 
an alternative, an area-based socioeconomic measure was created. Principal 
components analysis was used to create a summary measure of SES by analyzing 
the variables created from census data defined in Table 3.1. The selection of these 
variables was based on studies by Krieger and colleagues (7, 8) which discussed 
choosing area-based socioeconomic measures to monitor social inequalities and 
validation of census-based methodology. From the principal component analysis 
score, quartiles were created to rank each census tract in four levels of low to high 
SES. 
 
Statistical Analysis 
Data analysis was performed using STATA v8. Characteristics of the study 
population were examined. GIS was used to spatially represent the data. Crude 
bivariate analysis examined potential associations between demographic and 
geographic risk factors and no repeat screen. A backward elimination strategy was 
used to reduce the model. All variables were included in the initial model, the 
variable with the largest p-value was removed and the model reanalyzed. In theory, 
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this method should be repeated until all remaining p-values are significant at p<0.05. 
However, once the removal of non-significant variables affected the effect measure 
of statistically significant variables, all remaining variables were retained in the final 
model. Logistic regression, adjusted for clustering by county, was used to examine 
individual- and community- level risk factors for lack of a repeat screen. This 
adjustment accounted for potential clustering of infant within the same county 
because of similar community characteristics. Using interaction terms of each 
variable and study year, logistic regression analysis was also used to determine if 
any trends existed over time.  
 
Results 
 During the four year study period, 2028 infants had a borderline abnormal 
result on their initial newborn screen. Approximately 9% of these infants did not have 
a repeat screen submitted (Table 3.2). Among those who submitted a repeat screen, 
about 2% were later diagnosed with an IEM (Table 3.2).  
From the GIS map in Figure 3.2, the cases (n=175) appear fairly well-
distributed throughout the state with some clustering in areas likely due to the 
presence of a major city and thus, a higher population. The control group was 
comprised of the 91% of infants (n=1853) who had a repeat screen submitted. 
Among the controls, only 58% of infants had a repeat screen submitted within the 
desired window of 14 days and therefore did not require a parental letter to be sent 
(Table 3.2).  Of the controls who were sent the parental letter, 18% of families did 
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not receive the letter. A greater proportion of cases did not receive the parental letter 
(27%) commonly due to problems with the provided address (Table 3.2).  
The characteristics of the cases and controls were examined and are shown 
in Table 3.3. Race/ethnicity as well as the distance to their PCP varied between 
cases and controls; however, other infant characteristics were fairly similar. While 
the type of community and availability of PCP were similar, the SES of their 
community varied between cases and controls. Controls were more evenly 
distributed across SES quartiles. Cases had higher representation in the lowest SES 
quartile (32%) and lower proportion in the highest SES quartile (19%). Young 
maternal age (cOR 1.7, 95% CI 1.1, 2.5) had a crude association with lack of repeat 
screen. Likewise, low level of maternal education (cOR= 2.1, 95% CI 1.4, 3.2) also 
showed unadjusted association with lack of repeat screen.  
 The final adjusted model included the variables listed in Table 3.4. Hispanic 
infants (AOR 2.1, 95% CI 1.2, 3.8) and black infants (AOR 1.9, 95% CI 1.2, 3.1) 
were twice as likely to have no repeat screen as white infants. Infants who lived in 
communities in the lowest quartile of SES (AOR 2.3, 95% CI 1.4, 4.0) had a greater 
risk of no repeat screen. Not receiving the parental letter (AOR 1.6, 95% CI 1.1, 2.4)) 
was also associated with no repeat screen. Infant’s distance to their physician, 
maternal age and maternal level of education had crude associations with no repeat 
screen, but these associations were not significant after adjusting for other factors. 
The trend analysis showed no differences in the associations with lack of repeat 
screen submission over time (data not shown). 
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Discussion 
 This study examined repeat screen submission after an initial borderline 
abnormal screen and factors associated with failure to submit this indicated repeat 
screen. For 9% of infants with a borderline abnormal screen, a repeat screen was 
not submitted. It is likely that some of these infants had follow-up testing elsewhere 
or their physician moved directly to confirmatory testing. If an infant was missed by 
newborn screening, one would expect most infants with IEM to present 
symptomatically in the first few years of life. No known missed cases of IEM have 
arisen among infants for whom a repeat screen was not submitted in this 
retrospective study. These infants without a repeat screen represent a population at 
higher risk for having an IEM.  In this study, the positive predictive value for being 
diagnosed with an IEM after an initial borderline abnormal result was 1.7%. For 
infants whose repeat screen was also abnormal after an initial borderline abnormal 
result, the positive predictive value was on average 33% in North Carolina (4). 
Beyond its use in identifying infants with IEM, a repeat screen represents no 
financial cost to the family compared to confirmatory tests which can be more 
invasive, costly and cause unnecessary stress for families. 
 The parental notification letter was an important motivator in obtaining a 
repeat screen. Since repeat screens were less likely to be submitted for Hispanic 
infants, adapting this letter to better address the needs of this population might 
increase the response from this letter. At the time of the study, only an English 
version of this letter was sent out. After presenting these findings to the North 
Carolina Newborn Screening Advisory Board, a bilingual letter was proposed. In 
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addition, many families did not receive the notification letter due to incorrect mailing 
addressed or other delivery problems. This study could not follow-up on the source 
of the error in mailing address. However, it is likely that many families moved or the 
specimen submitter did not record the most appropriate address. Further 
community-based follow-up when a letter is returned undelivered may improve the 
submission rates of repeat screens. 
 While notifying the parents has been a good solution to ensuring an eventual 
repeat screen, the desired response is that the PCP follows-up on abnormal screens 
and submits a timely repeat screen within 14 days. The North Carolina Newborn 
Screening Program has noted problems with the accuracy of the designated PCP 
provided by the specimen submitter, usually the birth hospital. Education of 
physicians and hospitals about their role and responsibility in the follow-up of 
abnormal screens and understanding of how the lab uses the information they 
provide may help with some of these issues. 
Despite controlling for community factors such as neighborhood SES, Black 
and Hispanic infants were still at high risk of not having a repeat screen submitted. 
The impact of race and ethnicity was similar to findings in a study of newborn 
screening in the state of Washington where all newborn have a second screen (9). 
This study found that infants whose mothers were White, over 20 years of age, and 
high school graduates were more likely to receive this routine second screen (9). 
Race and ethnicity were shown to be risk factors with Black, Hispanic and especially 
Native American infants less likely to receive the second screen (9). Many other 
studies have demonstrated disparities in basic health services related to race, 
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income and other factors (10). Black children have been found to be two times more 
likely and Hispanic children three times more likely to lack a usual source of care 
even when health insurance and socioeconomic status (SES) were held constant 
(11). Similar results were found among poor children when race and neighborhood is 
constant (10, 12). Newborn screening programs rely on the medical home or usual 
source of care to follow-up infants with abnormal screens. Thus, it can be expected 
that these disparities seen in other areas of child health affect newborn screening 
services. 
This study was able to consider community-level factors in addition to 
individual-level characteristics. Community factors have been found to play a role in 
successful interaction with health care systems (13). Infants living in a neighborhood 
of low SES were less likely to have a repeat screen submitted. In unadjusted 
analysis, factors such as distance to PCP, maternal age, and maternal education 
had an expected association with repeat screen submission. Once adjusted for 
community factors, only a subtle relationship with young maternal age remained. It 
was also surprising that the availability of PCPs in the county did not have an effect 
on repeat screen submission. This may be due to the fact that the designation of 
counties was too broad or that most families seek the recommended routine infant 
check-up despite challenges such as lack of providers in the local area.  
In summary, most infants with a borderline abnormal newborn screen have 
the requested repeat screen. However, this study showed that a number of infants 
did not have a repeat screen submitted. Because this population is at higher risk for 
IEM than infants with normal screens, even one infant failing to be re-screened is 
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one potential missed diagnosis of IEM. Despite the notification of the infant’s 
physician, a parental letter was frequently needed to prompt a repeat screen. Black 
and Hispanic infants, those living in a neighborhood of low SES and those who fail to 
receive the parental letter were less likely to have had a repeat screen submitted. 
Thus, strategies to address the specific needs of these populations may increase the 
success and efficiency in submission of a repeat screen and reduce the risk of 
delaying IEM diagnosis. 
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Table 3.1 Definition of Selected Variables Created from 2000 United States 
Census Data Used to Create Community-based Socio-economic Index 
Variable Definition 
Working Class Percent of persons employed predominantly in working 
class occupations using the following 5 census based 
occupational groups: service (except protective); sales and 
office; farming, fishing and forestry; construction, extraction 
and maintenance; production, transportation and material 
moving 
Professional Class Percent of persons employed predominantly in 
professional class occupations using the following 2 
census based occupational groups: management, 
professional, and related; professional and related; 
protective services 
Unemployment Percent of persons age 16 and older in the labor force who 
are unemployed 
Median Household 
Income* 
Median household income in 1999 
Low Income Percent of households with <50% of US median income 
High Income Percent of households with income >400% of US median 
income 
Below Poverty Percent of persons below federally defined poverty line 
Low Education Percent of persons age 25 and older with less than a 12th 
grade education 
High Education Percent of persons age 25 and older with at least four 
years of college 
Urban Percent of persons who live in an urban designated area 
Rural Percent of persons who live in a rural designated area 
Household Movement Percent of persons who lived in a different house in 1995 
County Movement Percent of persons who lived in a different county in 1995 
*Median household income used to create low and high income variables, not included in PCA 
analysis. 
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Figure 3.1 Diagram of North Carolina Metabolic Newborn Screening Follow-up 
Procedure with Two-tiered System of Abnormal Cutoff and Follow-up 
Infant 
Birth
Specimen 
Collection
Specimen 
Analyzed 
(n=366,444) 
(~92,000/yr)
Normal 
(n=89756) 
(~22,000/yr)
Abnormal, 
Diagnostic Level 
(n=160)    
(~40/yr)
Abnormal, 
Borderline Level 
(n=2028) 
(~500/yr)
Report to Provider,      
No Repeat Requested
Report to Provider,  
Repeat Requested
Call to Provider,  
Diagnostics Testing 
Requested
No Repeat Screen in 14d 
(n=953)                     
(~240/yr)
Repeat Screen 
(n=1075) 
(~270/yr)
Certified Letter to Parents 
(letter received, refused, 
stopped or undeliverable)
Diagnostic 
Testing
No Repeat Screen 
(n=175)     
(~40/yr)
Repeat Screen 
(n=778) 
(~190/yr)
Infant/Family Characteristics
-race / ethnicity
-gestational age
-distance to health care provider
-maternal age 
-maternal education
*
*
*
* *
*Web-based and mailed NBS 
reports and recommendations 
sent to PCP and to submitter 
for all newborns
Normal Abnormal
* *
Community Characteristics
-SES
-urban / rural 
-PCP ratio 
Study Focus
Normal
Abnormal*
*
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Figure 3.2 Map of North Carolina Denoting the Location of Infants with No 
Repeat Screen Submission to the State Laboratory 
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Table 3.2 Summary of Follow-up Outcomes and Parental Letter After 
Borderline Abnormal Screen 
Risk Factors Total Sample n (%) 
Repeat Screen
n (%) 
No Repeat Screen 
n (%) 
Repeat Screen 
Repeat Screen 1853 (91%) - - 
 No Repeat Screen 175 (9%) - - 
Diagnosis 
Diagnosed with IEM 34 (1.7%) 34 (1.8%) 0 (0%)* 
 No Diagnosis 1994 (98%) 1819 (98%)   175 (100%)  
Parental Letter  
No Letter Necessary  1075 (53%) 1075 (58%) 0 (0%) 
 Letter Sent & Received 766 (38%) 638 (34%) 128 (73%) 
 Letter Sent & Not Received 187 (9%) 140 (8%) 47 (27%) 
 
Reason Letter Not Received  
Incorrect Address 79 (42%) 57 (41%) 22 (52%) 
 Returned (unclaimed/ attempted/ 
 refused) 
75 (40%) 55 (39%) 20 (48%) 
 Unknown 33 (18%) 28 (20%) 5 (12%) 
* No reported undiagnosed inborn error of metabolism missed from newborn screening. 
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Table 3.3 Description of Infants by Repeat Screen Status and the Unadjusted 
Association of Infant Characteristics with Lack of Repeat Screen 
 Risk Factors Repeat Screenn (%) 
No Repeat Screen
n (%) 
Crude OR  
(95% CI) 
Demographic 
Gender    
 Male 910 (49%) 83 (48%) 1.0 
 Female 935 (51%) 91 (52%)  1.1 (0.8, 1.5) 
 
Race / Ethnicity    
 Non-Hispanic White 894 (48%) 42 (24%) 1.0 
 Non-Hispanic Black 492 (27%) 60 (34%)  2.6 (1.7, 4.0) 
 Non-Hispanic Other Race 135 (7%) 19 (11%)  3.0 (1.6, 5.4) 
 Hispanic 332 (18%) 54 (31%)  3.5 (2.2, 5.4) 
 
Gestational Age (weeks) x = 35.6 [4.4] x = 35.4 [4.9]  -
Term (H37 wks) 1025 (55%) 92 (53%) 1.0 
 Preterm (<37 wks) 828 (45%) 83 (47%)  1.1 (0.8, 1.5) 
 
Age at Screen Collection (hr) x = 49.2 [90.5] x = 53.1 [68.3]  -
Birth Weight (grams) x = 2678 [970] x = 2529 [1034]  -
Distance to Physician (miles) x = 13.5 [17.4] x = 16.4 [29.5] -
T 25 miles 1586 (86%) 139 (79%) 1.0 
 >25 miles 267 (14%) 36 (21%)  1.5 (1.0, 2.3) 
 
Community-Level Information  
County Type    
 Metropolitan 1292 (70%) 121 (69%) 1.0 
 Non-Metropolitan 561 (30%) 54 (31%)  1.0 (0.7, 1.5) 
 
County PCP Ratio† x = 8.5 [4.4] x = 8.7 [4.9] -
<5 PCP per 10,000 201 (11%) 25 (14%)  1.5 (0.9, 2.4) 
 5-9 PCP per 10,000 1341 (72%) 113 (65%) 1.0 
 H 10 PCP per 10,000 311 (17%) 37 (21%)  1.4 (0.9, 2.1) 
 
Census Tract SES Index     
 Quartile 1 (Low SES) 400 (22%) 56 (32%)  2.3 (1.4, 3.6) 
 Quartile 2 465 (25%) 45 (26%)  1.5 (0.9, 2.5) 
 Quartile 3  462 (25%) 41 (23%)  1.4 (0.9, 2.4) 
 Quartile 4 (High SES) 526 (28%) 33 (19%) 1.0 
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Table 3.3 Description of Infants by Repeat Screen Status and the Unadjusted 
Association of Infant Characteristics with Lack of Repeat Screen (Continued) 
Risk Factors Repeat Screenn (%) 
No Repeat Screen
n (%) 
Crude OR  
(95% CI) 
Maternal Characteristics 
Maternal Age x = 26.6 [5.9] x = 25.3 [6.3]  -
Adult Mom (H20 yrs) 1628 (88%) 142 (81%) 1.0 
 Teen Mom (<20 yrs) 225 (12%) 33 (19%)  1.7 (1.1, 2.5) 
 
Maternal Education    
 Less than High School 475 (26%) 73 (42%)  2.1 (1.4, 3.2) 
 High School 591 (32%) 43 (25%) 1.0 
 Greater than High School 784 (42%) 57 (33%)  1.0 (0.7, 1.5) 
 
Parity    
 Primipara 607 (33%) 57 (33%)  1.0 (0.7, 1.4) 
 Multipara 1246 (67%) 118 (67%) 1.0 
x = Mean [Standard Deviation] 
† County ratio of primary care physicians per 10,000 individuals 
‡ Index created by principal component analysis of 2000 Census Variables representing occupation, 
income, education, employment status, stability, and urban/rural designation. 
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Table 3.4 Adjusted Odds and 95% Confidence Intervals for the risk of No 
Repeat Screen Submission by Risk Factor  
 Risk Factors AOR 95% CI 
Demographic 
Race / Ethnicity   
 Non-Hispanic White 1.0 - 
 Non-Hispanic Black 1.9 1.2, 3.1 
 Non-Hispanic Other Race 2.5 1.4, 4.4 
 Hispanic 2.1 1.2, 3.8 
Preterm 1.2 0.8, 1.6 
>25 Miles to Physician (miles) 1.2 0.8, 1.9 
Parental Letter Not Received 1.6 1.1, 2.4 
Community-Level Information  
Metropolitan County 0.85 0.6, 1.3 
Census Tract SES Index‡
Quartile 1 (Low SES) 2.3 1.4, 4.0 
 Quartile 2 1.5 0.9, 2.5 
 Quartile 3  1.6 0.9, 3.0 
 Quartile 4 (High SES) 1.0 - 
Maternal Characteristics 
Teenage Mom 1.7 1.0, 3.0 
Maternal Education   
 Less than High School 1.5 0.9, 2.6 
 High School 1.0 - 
 Greater than High School 1.5 0.8, 2.9 
Primipara  0.90 0.6, 1.1 
AOR= Adjusted Odds Ratio  
Each risk factor adjusted for other factors in table and adjusted for clustering by county.  
‡ Index created by principal component analysis of 2000 census variables representing occupation, 
income, education, employment status, stability, and urban/rural designation. 
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CHAPTER 4 
 
METABOLIC NEWBORN SCREENING KNOWLEDGE  
AND CLINICAL PRACTICES:  
SURVEY OF NORTH CAROLINA PEDIATRIC SOCIETY PEDIATRICIANS 
 
Abstract 
Pediatricians are an important partner to newborn screening programs; they 
are relied upon to ensure sample collection, follow-up on abnormal results, 
communicate results to families, and ensure enrollment into appropriate specialty 
care. However, studies to date have not thoroughly examined pediatricians’ 
knowledge regarding their state’s newborn screening policies nor how well clinical 
practices align with the desired response to newborn screening results. This study 
utilized a self-administered paper questionnaire to survey pediatricians attending 
three North Carolina Pediatric Society meetings held between March and August 
2004. The response rate was 30%. Most pediatricians had experience with abnormal 
newborn screens (93%) and infants subsequently diagnosed with a disorder (80%). 
However, about half of the participants ranked themselves in the lower ranges 
regarding level of knowledge and comfort in communicating screening results. Self-
described knowledge was correlated to self-described comfort (r=0.35). Only 57% of 
pediatricians correctly answered more than three of seven questions relating to 
newborn screening and state policies. While most pediatricians (75%) ensured that 
they received screening results prior to an infant’s initial visit, 15% of pediatricians 
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assumed that results were normal even when they had not received a screening 
result. Many pediatricians (32%) did not inform families of results when the newborn 
screen was normal. These findings suggest a need to further educate pediatricians 
about newborn screening and its related policies. Providing opportunities for 
pediatricians receive more information about newborn screening in North Carolina 
may be beneficial in improving pediatrician understanding of their expected role and 
their desired clinical practices surrounding newborn screening. 
 
Introduction 
Primary care physicians such as pediatricians play an integral role in the 
efficiency and effectiveness of a newborn screening program. Pediatricians are 
relied upon to ensure sample collection, follow-up on abnormal results, communicate 
results to families, and ensure enrollment into appropriate specialty care (1-4). The 
American Academy of Pediatrics (AAP) supports this role for pediatricians since they 
are often the source of a child’s medical home. The AAP recommends that 
pediatricians “take responsibility for the coordination of the newborn screening 
process from initial screening through diagnosis and treatment”(4).  
However, a public health program that assigns responsibility to pediatricians, 
who are mostly in private practice, can present challenges (4). Effective 
collaboration and communication must occur among all aspects of the newborn 
screening system which includes the state program, medical home and genetic 
clinics, which specialize in metabolic disorders (5). Additionally, the system relies on 
pediatricians not only to be informed about newborn screening, but also to be 
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comfortable conducting preliminary genetic counseling (4). Pediatricians may not be 
aware of their state’s protocols due to the rarity of the screened disorders (4). A lack 
of understanding about the newborn screening system or belief in its benefits may 
put infants at risk for delayed diagnosis due to lack of proper follow-up.  
Studies have generally surveyed newborn screening programs to assess 
issues about metabolic newborn screening (6, 7). Few studies have directly 
assessed pediatricians’ awareness, involvement and interaction with the newborn 
screening system (1, 8, 9). One study by Desposito and colleagues (1), which used 
a mailed questionnaire to survey primary care physicians in the United States, found 
that most are generally satisfied with the communication from the state newborn 
screening program. However, studies of affected infants who were missed by 
newborn screening often found the breakdown to be at the physician level (7, 10).  
Another possible problem is that a significant number of pediatricians do not 
actively seek screening results, assume no news is good news, and do not tell 
parents when the screening result is normal (1, 4). This lack of engagement could 
delay the identification and subsequent treatment of an infant with a disorder. The 
Newborn Screening System Guidelines from the Council of Regional Networks for 
Genetic Services state that it is the primary health care professional’s responsibility 
to “obtain and maintain a copy of results of newborn screening testing for every child 
in their practice and be sure the mother or guardian is apprised of the result” (3).  
Despite the critical role of pediatricians in the newborn screening system, no 
known studies have looked at how much they know about the purpose of newborn 
screening and their expected role in the system. The North Carolina Newborn 
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Screening Program was interested in understanding pediatricians’ awareness of 
newborn screening protocols and their expected role in the program. Understanding 
pediatricians’ level of awareness can provide screening programs with what 
information needs to be disseminated to the pediatricians. Thus, this study explored 
pediatricians’ knowledge of the North Carolina newborn screening policies, their 
clinical protocol for handling newborn screening results and their personal beliefs 
about the utility of newborn screening.   
 
Methods 
Study Population 
Eligible study participants included North Carolina physicians who attended 
one of the following three meetings of the North Carolina Pediatric Society (NCPS) 
in 2004:  the Spring Forum (March 2004), the Open Forum (April 2004) and the 
Annual Meeting (August 2004). The NCPS (also known as The North Carolina 
Chapter of the American Academy of Pediatrics) represents over 1,200 pediatricians 
in the state. Beyond these pediatricians, its membership also includes family 
practice physicians, pediatric residents, medical students and allied health 
professionals.  
 
Materials 
A self-administered anonymous paper survey was developed and used to 
assess a pediatrician’s knowledge of newborn screening and their current newborn 
screening practices (See Appendix 1). The survey contained multiple-choice 
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questions with options for comments on clinical practices, knowledge of newborn 
screening procedures and general opinions related to newborn screening.  
 
Data Collection 
The surveys were placed on the seats for all attendees prior to each meeting. 
At the beginning of each meeting, a brief introduction to the survey was given and 
physicians who see children as part of their practice were requested to participate. 
Approximately 10 minutes were provided at the beginning of the meeting to 
complete the survey. Surveys were collected at the close of the meeting to allow 
additional time throughout the day for additional opportunities to participate. As 
indicated orally and on the survey, the participants returned the completed survey to 
a designated collection box.  
 
Statistical Analysis 
Data analysis was performed using STATA v8. Demographic information on 
those who participated was compared to all meeting attendees to determine if 
survey participants were representative of those attending the NCPS meetings. 
Responses to the survey questions were summarized. A knowledge score was 
created from the number of correct answers given on the seven questions relating to 
knowledge of newborn screening policy. One point was given for each correct 
answer to create the knowledge score, a categorical ranking of pediatrician 
knowledge: not knowledgeable (0-1 points), somewhat knowledgeable (2-3 points), 
knowledgeable (4-5 points) and very knowledgeable (6-7 points). Similarly, an 
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experience score was created from responses to four clinical practice questions: 
assessment of the number of patients seen per week (one point if >5 infants/week), 
whether the pediatrician personally reviewed the newborn screening results, whether 
the pediatrician ever had a patient with an abnormal screen and finally, whether the 
pediatrician ever had a patient diagnosed with a disorder. This score was used to 
create a categorical ranking of experience: low experience (0-1 points), medium 
experience (2-3 points), and high experience (4 points). Perceived knowledge and 
perceived comfort was determined from the pediatrician’s selection on the 4-level 
rank scale (no neutral selection provided) (Appendix 1). Correlations between actual 
knowledge, perceived knowledge, perceived comfort and experience were 
examined. The Spearman rank correlation test was used to examine correlation of 
these categorical rank variables.  
Results 
Demographic Analysis 
 Of the 223 attendees of the three NCPS meetings, 66 pediatricians, with no 
duplication, participated in the survey for a 30% response rate. The Spring Forum 
(47% response rate) and the Open Forum (30% response rate) were smaller one-
day meetings with approximately 30 physicians in attendance. The Annual Meeting 
(27% response rate) spanned several days and had 166 physicians in attendance. 
Only geographic information was available on non-participants. The geographic 
representation was fairly similar among those who completed the survey compared 
to the entire population of meeting attendees. Slightly higher representation was 
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found from the eastern counties compared to the central counties among survey 
participants. Of the eligible physicians, 29% (n=64) were from Eastern North 
Carolina, 69% (n=154) from Central North Carolina and 2% (n=5) from Western 
North Carolina. Of the 66 survey participants, 39% (n=25) were from Eastern North 
Carolina, 59% (n=38) from Central North Carolina and 2% (n=1) from Western North 
Carolina (Table 4.1).  
 The demographic characteristics of the survey participants are presented in 
Table 4.1. There were similar numbers of male and female pediatricians. The mean 
number of years since medical school graduation was 20.6 years. Almost all 
participants were pediatricians (94%) from a group practice (73%).  
 
Responses to Knowledge Questions 
 Seven questions were used to examine pediatricians’ knowledge of the 
newborn screening policies (Table 4.2). Figure 4.1 shows the percent of correct and 
incorrect responses to these knowledge questions. Detailed responses are 
described in Table 4.3. Only 14% of pediatricians were able to correctly identify that 
the recommended age to collect the initial newborn screen is at 48-72 hours. Most 
pediatricians (79%) believed the screen should be collected earlier, at 24-47 hours 
of age. Many pediatricians selected the response option noting that they were 
unsure of how the screening lab follows-up when no repeat screen is submitted 
(23%), of who pays for confirmatory testing (26%) and that there was an age 
restriction in newborn screening (25%). Most pediatricians (63%) incorrectly selected 
that the responsibility for payment of confirmatory testing fell upon the State Lab. 
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While most pediatricians identified at least one of the two main goals of newborn 
screening, only 55% of pediatricians correctly selected both of these goals.  
 The pediatricians were asked to rank how knowledgeable they felt they were 
on the subject of newborn screening procedures and follow-up (Table 4.4). Nearly 
half of the pediatricians (49%) felt that they had a low level of knowledge (not 
knowledgeable and somewhat knowledgeable) with about 9% of pediatricians 
selecting the lowest level of knowledge. Regarding actual knowledge, 43% of 
pediatricians were considered to have low levels of actual knowledge by not 
correctly responding to over half of the knowledge questions (Table 4.4). No 
correlation was found between perceived and actual knowledge (Table 4.7). 
 
Responses to Clinical Practice Questions 
 Table 4.5 presents survey questions relating to pediatricians’ clinical practices 
with recommended procedures. A summary of responses to questions on clinical 
practices and experience is described in Table 4.6. Pediatricians who did not see 
patients (n=4) were not asked to complete this section of the survey. Most 
pediatricians have had a patient with an abnormal screen (93%) as well as an infant 
diagnosed with a disorder (80%). Many pediatricians (32%) indicated that they would 
not relay normal screening results to the family. While most pediatricians (75%) 
would seek out screening results if they had not received it by the infant’s initial clinic 
visit, 15% would assume results were normal and 10% would wait until later visits or 
older child ages to check. If a patient had a borderline abnormal result, 89% 
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appropriately indicated that they would contact the family to schedule an 
appointment for repeat screen in a timely manner.  
 Many pediatricians indicated that they were comfortable (32%) explaining 
abnormal screening results to families (Table 4.7). Some pediatricians (32%) 
indicated that their comfort level depended on which metabolite was abnormal.  Over 
half of the pediatricians had high experience (55%) (Table 4.7).  No correlation was 
found between actual knowledge and pediatrician’s perceived comfort level (Table 
4.8). Experience level and perceived comfort showed a slight but non-significant 
correlation of r= 0.29 (p=0.06) (Table 4.8). However, there was a correlation seen 
between perceived knowledge and perceived comfort (r= 0.35 (p=0.02)) (Table 4.8). 
 
Responses to Belief Questions 
 Two questions were used to gather pediatricians’ beliefs on the type of 
disorders for which to screen (Table 4.9). Almost all pediatricians (98%) felt that 
disorders with neonatal onset should be included on the newborn screening panel. 
The majority felt it would also be appropriate to screen for disorders with adult onset 
(59%) and untreatable disorders for which identification would allow for future 
planning (73%). Beliefs about the screening for specific disorders are described in 
Table 4.9.  
 The majority of pediatricians felt that using the North Carolina Pediatric 
Society to disseminate newborn screening information through their publications 
(67%) or website (62%) would be useful (Table 4.9). CME lectures (55%) and grand 
rounds (56%) also seemed to be useful methods to provide education. Informational 
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booklets (41%) had a lower perceived usefulness. Some individual suggestions from 
write-in responses were to use email notifications, create a newborn screening 
newsletter or present an annual workshop. 
 
Discussion 
 Pediatricians involved in newborn screening play a critical role in the system, 
especially with regard to follow-up of abnormal screens and communication with 
families. Since knowledge and beliefs have been theorized to affect behavior (11), 
knowledge about newborn screening may affect a pediatrician’s perceived and 
actual ability to appropriately incorporate newborn screening into their clinical 
practices. This study explored what a subset of North Carolina pediatricians knew 
about newborn screening, how newborn screening was incorporated into their 
practices and their beliefs about disorders included in newborn screening. 
 Most pediatricians who participated in this study had previous experience with 
patients who had abnormal screens and/or were diagnosed with a disorder after 
identification by newborn screening. This high level of experience was surprising 
because rates of diagnosed metabolic disorders are low in the population. This may 
be due to a misinterpretation of the question as including other disorders screened 
such as hearing impairment, hypothyroidism and sickle cell rather than only those 
from inborn errors of metabolism. Also, most reported several years of practices 
since medical school graduation which would allow more opportunities to experience 
a patient with a diagnosed metabolic disorder. Despite the high level of experience, 
almost half of the pediatricians ranked themselves in lower half of a knowledge scale 
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relating to their knowledge of newborn screening policies. Similarly, half of the 
pediatricians surveyed felt either uncomfortable or very uncomfortable relaying 
abnormal results to families or that their comfort depended on the abnormal 
metabolite. Perceived knowledge was related to a pediatrician’s comfort with 
newborn screening. Thus, by strengthening a pediatrician’s knowledge of newborn 
screening, the program procedures and their expected role, improvement  should be 
seen in their comfort performing newborn screening related tasks such as 
communicating with families and following up on results.  
 Less than half of the pediatricians correctly answered the majority of the 
questions on screening procedure and goals. For a number of questions, 
approximately 25% were unsure of the correct answer when given multiple 
selections. In particular, there appeared to be confusion regarding the recommended 
age to administer the newborn screen. Most pediatricians tended to select an earlier 
age and some commented that screens should be taken only after the infant was 
feeding well.  
 The majority of pediatricians have appropriate protocols for following up 
newborn screening results. However, better communication of recommended 
practices by the Newborn Screening Program may further improve how newborn 
screening is handled by all pediatricians. For example, many pediatricians do not 
relay normal screening results to families. Parents may not be aware of where to 
seek newborn screening test results since the blood samples were taken at the birth 
hospital. Similarly, some pediatricians assume results are normal if they have not 
received a result although the observed rate of 15% was much lower than the 80% 
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reported in another study (1). It is expected that the infant’s pediatrician will not only 
follow-up on screening results but communicate these results to families. If a result 
is abnormal, this delay or lack of action could put an infant at risk for not being 
diagnosed pre-symptomatically and reduce the effectiveness of newborn screening. 
 These findings indicate a need to further educate pediatricians about the 
newborn screening procedures and their expected role. Most pediatricians felt it best 
to be kept apprised of newborn screening through resources from the North Carolina 
Pediatric Society (NCPS) via newsletters, publications or the website. While this 
response is likely related to the fact that the respondents were in the NCPS and 
participating in a NCPS meeting, most pediatricians in North Carolina belong to the 
NCPS. Thus, utilizing this resource base may be an effective method of 
communication. 
 It was hypothesized that actual knowledge would correlate with perceived 
knowledge and perceived comfort, and that the level of experience in newborn 
screening would correlate with perceived comfort. The lack of correlation suggests 
that pediatricians do not know as much about newborn screening as they feel they 
know. Perceived knowledge and perceived comfort did significantly correlate 
although with a low correlation coefficient. This relationship was expected as feeling 
knowledgeable is an important factor in confidence and being comfortable with a 
behavior (11).   
 In reviewing pediatricians’ opinions about the disorders chosen for the 
newborn screening panel, it was interesting to note that despite the fact that most 
recognized the goals of pre-symptomatic identification in newborn screening and 
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prevention of negative health outcomes through early treatment. However, many 
pediatricians still felt it would be appropriate to screen for disorders with adult onset 
or disorders that were untreatable but could help in planning future pregnancies. 
These opinions suggest that while pediatricians understand the current use of 
newborn screening, they are interested in expanding its use as a tool in other areas 
of clinical care such as genetic counseling or predicting future risks.  
This study examined an important partner in the newborn screening program, 
the pediatrician. The study takes a novel look at how pediatricians understand and 
use newborn screening in their practices. Since this survey was conducted, 
Gennaccaro and colleagues (9) have published findings about pediatricians’ 
preparedness to discuss metabolic newborn screening with families and desired 
education sources from their mail survey of the 550 pediatricians listed in the 
Massachusetts Healthcare Directory. They found that 54% of pediatricians felt less 
comfortable talking about screening results, 54% indicated a lack of information 
about expanded screening, and education via mailings, grand rounds, seminars and 
websites were preferred. These findings along with the findings in the current study 
suggest that low level of pediatrician knowledge and comfort with expanded 
newborn screening is a challenge facing many newborn screening programs. 
A limitation was that the survey relied on self-report and that actual behaviors 
were not observed. The study had a low response rate although similar to the 
response rates found in the other surveys of pediatricians and newborn screening 
(1, 9).  Another limitation was the small sample size and limited generalizability to 
the larger population of all North Carolina pediatricians. This study was restricted to 
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NCPS pediatricians who attended organized meetings during specific time-frame. 
People who attend information-based meetings, such as those organized by NCPS, 
may be more knowledgeable than non-attendees and among attendees, those who 
complete the survey, may be more motivated or interested in the topic and thus, 
more knowledgeable. It is likely that these results overestimate the knowledge of the 
general population of North Carolina pediatricians. Since an improvement in the 
level of knowledge and desired clinical practices was indicated, in actuality this need 
for increased training or information dissemination about newborn screening in North 
Carolina may be even greater than observed in this study.  
Overall, this study found that North Carolina pediatricians attending NCPS 
meeting have fair knowledge about newborn screening policies but that there is a 
need to increase this level of knowledge to improve clinical practices and 
pediatrician comfort in communicating newborn screening results. Approximately 
half of pediatricians feel that they have low levels of knowledge and comfort in 
performing newborn screening tasks. Likewise, questions addressing actual 
knowledge found that approximately half the pediatricians have lower scores of 
knowledge. Providing opportunities for pediatricians to learn or receive more 
information about newborn screening in North Carolina may be beneficial in 
improving pediatricians’ understanding of their role and desired clinical practices. A 
more comprehensive survey with state-wide representation would assess the unmet 
education needs of pediatricians and provide direction on where to focus pediatrician 
education surrounding newborn screening and their expected role in the screening 
and follow-up system. 
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Table 4.1 Demographic Characteristics of North Carolina Pediatric Society 
Pediatricians Participating in Survey on Metabolic Newborn Screening 
 Demographic Information % (N) 
Total Participants N=66 
Gender  
Male 48% (32) 
 Female 52% (34) 
Number of Years Since Medical School Graduation x =20.6 (SD 10.8) 
 < 10 yrs 26% (17) 
 11-20 yrs 27% (18) 
 >20 yrs 57% (31) 
Type of Practitioner  
Pediatrician 94% (62) 
 Family Practitioner 0% (0) 
 Other 6% (4) 
Type of Practice  
Solo/Private 2% (1) 
 Group 73% (33) 
 Government* 2% (1) 
 Academic* 11% (5) 
 Resident* 11% (5) 
Location of Practice  
Eastern NC 39% (25) 
 Central NC 59% (38) 
 Western NC 2% (1) 
N=66 
* Created from write-in responses for “other” answers 
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Table 4.2 Survey Questions Addressing Knowledge of the North Carolina 
Newborn Screening Program and Responses per North Carolina Policy 
K1. What is the recommended age for taking the first newborn screen? 
 - Optimum time for screening is 48-72 hours. 
 
K2.  If an infant is discharged from their place of birth prior to the recommended age for 
 screening, when should the blood specimen should be collected? 
 - Obtain blood specimen from every infant before discharge or transfer. 
 
K3.  If an infant has an abnormal metabolic newborn screen and no repeat specimen is 
 received within 14days, what does the screening lab do? 
 -The lab sends confirmed delivery mail to the mother to notify of abnormal result  
 and to request that the infant see their pediatrician for a repeat screen. 
 
K4.  Who pays for confirmatory testing after abnormal metabolic newborn screen? 
 -While the SLPH pays for all screening, confirmatory testing is paid for by the ordering     
 pediatrician / family or subsequent 3rd party payer if applicable. 
 
K5.  What is the goal of newborn screening? 
 -The two main goals of newborn screening are to 1- identify infants with treatable disorders 
 pre-symptomatically and 2- identify infants early to prevent or limit mortality/morbidity. 
K6.  You saw a 9-month old for the first time because they have moved here from another 
 state. The child has symptoms of a metabolic disorder (e.g. a strong maple syrup odor, 
 possible indicating Maple Syrup Urine Disease). Why won’t the newborn screening 
 laboratory run a blood spot from this child? 
 -The SLPH screens infants from birth to six months of age. 
 
K7.  You recently saw a newborn who was doing well, but shortly after, you receive a call 
 that this infant has an abnormal metabolite on their metabolic newborn screen (e.g. 
 glutaryl carnitine which is elevated in Glutaric Acidemia Type I). Would you be 
 concerned? 
 -Any abnormal result, even if an infant is well, is of concern as screening aims at identifying 
 infants pre-symptomatically. An abnormal result indicates a risk for having an inborn error of 
 metabolism and requires a repeat screen or confirmatory testing. 
67 
Figure 4.1 Percent Incorrect and Correct Responses of Pediatricians to 
Knowledge Questions on Metabolic Newborn Screening in North Carolina  
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Table 4.3 Summary of Responses to Knowledge Questions about the North 
Carolina Metabolic Newborn Screening Program  
 Questions Responses % (N) 
Recommended Age for Collecting Specimen -
0-24 hrs 3% (2) 
 24-47 hrs 79% (52) 
 48-72 hrs 14% (9) 
 >72 hrs 0% (0) 
 Unsure 2% (1) 
 After feeding well* 3% (2) 
When to Collect Specimen if Discharged Prior to 
Recommended Age of Collection -
Prior to discharge even though early 80% (53) 
 At first well-baby visit 5% (3) 
 After discharge but within 1 week* 15% (10) 
SLPH Action if No Repeat Screen is Received Within  
14d After Abnormal Screen -
Sends letter to mother 59% (39) 
 Contacts infant’s pediatrician 18% (12) 
 Pursues no further 0% (0) 
 Unsure 23% (15) 
Funding Source for Confirmatory Testing -
Ordering physician / family / 3rd party payers 13% (8) 
 SLPH 63% (41) 
 No charge 0% (0) 
 Unsure 26% (17) 
Goal of Newborn Screening -
Identify infants with treatable disorders pre-
 symptomatically 
80% (35) 
 Identify infants early to prevent or limit mortality / 
 morbidity 
75% (33) 
 Confirm diagnosis of a metabolic disorder 14% (6) 
 Identify infants with treatable disorders once they are 
 symptomatic 
2% (1) 
Reason State Lab Does Not Screen a 9-Month Old with 
MSUD Symptoms who Moved to NC From Another State‡ -
Child beyond age State Lab screens 66% (29) 
 Child is from another state 5% (2) 
 MSUD not detectable or screened for in NC 5% (2) 
 Unsure 25% (11) 
Concern if Abnormal Screen in Well Child -
Yes (indicates pre-symptomatic detection) 95% (63) 
 No 2% (1) 
N=66; Note: Answers considered correct are in bold 
* Created from write-in responses for “other” answers 
‡Question only available to 44 respondents. 
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Table 4.4 Summary of Pediatricians’ Perceived and Actual Knowledge on 
North Carolina Metabolic Newborn Screening 
 Questions Responses % (n=) 
Perceived (Self-Selected) Knowledge Level of 
Newborn Screening Procedure and Follow-up -
Not Knowledgeable 9% (6) 
 Somewhat Knowledgeable 40% (26) 
 Knowledgeable 45% (29) 
 Very Knowledgeable 6% (4) 
Actual Knowledge* -
Not Knowledgeable (0-1 correct) 5% (3) 
 Somewhat Knowledgeable (2-3 correct) 38% (25) 
 Knowledgeable (4-5 correct) 48% (32) 
 Very Knowledgeable (6-7 correct) 9% (6) 
N=66  
* Based on number of correct answers on 7 knowledge questions in Table 4.3 
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Table 4.5 Questions Addressing Pediatricians’ Clinical Practices Involving 
Metabolic Newborn Screening Program and Responses of Recommended 
Procedures 
C1. If you have not received a newborn screening report for a new patient by the 
 time of the initial visit, what do you do? 
-First, seek out screening results prior to visit via screening lab website or by contacting the 
 lab. If no screening result is found re-test the infant. 
 
C2.  If the metabolic newborn screening results are normal, is this information 
 relayed to the parents? 
-Normal as well as abnormal screening results should be relayed to families. 
 
C3.  If the metabolic newborn screening report indicates a borderline abnormal 
 result, what do you do? 
-The family should be contacted and infant scheduled for an immediate clinic visit for re-test 
 in order to allow for timely identification prior to onset of symptoms. 
 
C4.  Who pays for confirmatory testing after abnormal metabolic newborn screen? 
 -While the SLPH pays for all screening, confirmatory testing is paid for by the ordering     
 physician / family or subsequent 3rd party payer if applicable. 
 
C5.  If you are called because an infant has very elevated metabolites (diagnostic 
 abnormal) on a metabolic newborn screen, who would contact the family? 
-When an infant has an abnormal result in the diagnostic range, this indicates a very high 
 risk for having an inborn error of metabolism and the infant’s pediatrician are called by a     
 metabolic specialist to discuss confirmatory testing. The pediatrician is advised to notify the 
 family in order to respond to questions and arrange for testing. 
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Table 4.6 Summary of Clinical Practices with Metabolic Newborn Screens 
 Questions Responses % (n=) 
Number of New Infants Seen Per Week 
None 6% (4) 
 < 5 25% (16) 
 5-10 46% (30) 
 >10 23% (15) 
Ever Had Patient with Abnormal Screen  
Yes 93% (57) 
 No 7% (4) 
Ever Had Patient Diagnosed with Disorder  
Yes 80% (49) 
 No 20% (12) 
MD Reviews Newborn Screening Results 
Yes 89% (54) 
 No 12% (8) 
State Lab Website Used to Access Results  
Yes 87% (53) 
 No 13% (8) 
Normal Results Relayed to Parents  
Yes 68% (40) 
 No 32% (19) 
Action if No Results Received by Initial Clinic Visit  
Assumes results are normal 15% (9) 
 Contacts SLPH by phone or fax 5% (3) 
 Check State Lab website 60% (37) 
 Both calls SLPH & checks website* 10% (6) 
 Re-screens the infants 0% (0) 
 Waits until later visit (1-2 months) to check* 10% (6) 
Action After Borderline Abnormal Result  
Re-test at next regular visit 8% (5) 
 Contact family & see infant as soon as possible 89% (55) 
 Depends on abnormality* 3% (2) 
Person Notifying Families of Diagnostic Abnormal 
Screen 
 
Clinic support staff 11% (7) 
 Physician or RN/FNP/PA 56% (32) 
 RN/FNP/PA always 8% (5) 
 Physician always 24% (15) 
N=62 (If a pediatrician does not see patients (n=4), they were not asked to complete questions on 
clinical practices) 
Note: Bolded responses are desired clinical practices. 
* Created from write-in responses for “other” answers 
RN= Registered Nurse, FNP= Family Nurse Practitioner, PA= Physician Assistant 
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Table 4.7 Summary of Pediatricians’ Comfort Level and Experience Score with 
Metabolic Newborn Screening 
 Questions Responses % (n=) 
Perceived (Self-Described) Comfort in Explaining 
Abnormal Screen Results to Families  
Very Uncomfortable 8% (5) 
 Uncomfortable 8% (5) 
 Comfortable 32% (20) 
 Very Comfortable 19% (12) 
 Comfort depends on abnormal metabolite 32% (20) 
Experience Level*  
Low Experience  3% (2) 
 Medium Experience 42% (26) 
 High Experience 55% (34) 
N=62 (Note: If a pediatrician does not see patients (n=4), the did not complete questions on clinical 
practices) 
* Based on first 4 responses in Table 4.6 
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Table 4.8 Correlation Analysis of Knowledge, Comfort and Experience of 
Pediatricians with North Carolina Metabolic Newborn Screening 
 Variable 1 Variable 2 Correlation Coefficient (r) P-Value 
Actual Knowledge Perceived Knowledge -0.034 0.789 
Experience Level Perceived Comfort  0.292 0.060 
Actual Knowledge Perceived Comfort  0.020 0.900 
Perceived Knowledge Perceived Comfort  0.351 0.023 
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Table 4.9 Summary of Pediatricians’ Beliefs about Metabolic Newborn 
Screening  
 Questions Responses N (%) 
Disorders to Include on Newborn Screening Panel  
Disorders with Neonatal Onset of Symptoms  
 Yes 98% (42) 
 No 2% (1) 
Disorders with Adult Onset of Symptoms  
 Yes 59% (24) 
 No 41% (17) 
Untreatable Conditions but Identification Can Help in 
 Planning Future Pregnancies 
 
Yes 73% (30) 
 No 24% (10) 
Specific Disorders Appropriate to Screen Newborns  
Phenylketonuria  
 Yes 100% (66) 
 No 0% (0) 
Medium Chain Acyl-CoA Dehydrogenase Deficiency 
 (MCADD) 
 
Yes 92% (59) 
 No 8% (5) 
Cystic Fibrosis  
 Yes 71% (46) 
 No 29% (19) 
Huntington Disease  
 Yes 25% (16) 
 No 75% (48) 
Chromosomal Disorders  
 Yes 45% (20) 
 No 55% (24) 
Useful Educational Tools to Keep Informed about 
Newborn Screening 
 
Articles in the North Carolina Pediatrician 67% (44) 
 SLPH or NC Pediatrics Society website 62% (41) 
 Informational Booklets 41% (27) 
 CME Lectures 55% (36) 
 Grand Rounds 56% (37) 
 Other: Email, Annual Workshop, NBS Newsletter* 5% (3) 
* Created from write-in responses for “other” answers 
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CHAPTER 5 
 
RISK FACTORS FOR TRANSIENT ELEVATIONS OF TYROSINE IN NEWBORNS 
 
Abstract 
Unique from the inborn errors of metabolism of tyrosinemia I, II and III (IEMT), 
transient neonatal tyrosinemia (TNT) is indicated by abnormal elevations in tyrosine 
during the neonatal period that resolve in time. This disorder is problematic in 
newborn screening for IEMT as it causes high rates of false positive screens. 
Finding additional criteria to better screen for IEMT would reduce use of resources, 
financial costs, and stress to families. This study examined risk factors for transient 
tyrosine elevations in newborns screened by tandem mass spectrometry in North 
Carolina. As expected, being preterm was a large risk factor with crude odds ratios 
of 9.7 (95% CI 7.8, 12.2) as well as being small for gestational age (AOR 2.4, 95% 
CI 1.76, 3.24) likely due to immature enzyme 4-hydroxyphenylpyruvic acid 
dioxygenase (4-HPPD). Gestational age modified the effect of type of feeding on 
abnormal tyrosine. Contrary to previous studies, breast-fed term infants (AOR 6.0, 
95% CI 4.13, 8.62) were at higher risk than formula-fed term infants. Also, Hispanic 
infants (AOR 2.6, 95% CI 1.93, 3.53) were more likely to have elevated tyrosine 
compared to Non-Hispanic White infants. Thus, considering different criteria for 
abnormal tyrosine among varying gestational ages, types of feeding and ethnic 
groups may reduce the number of false positive screens for IEMT, although future 
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studies are needed to compare infants with TNT to IEMT. This study also draws 
attention to the need to further study TNT to better understand this phenomenon and 
explore any impact on the health and development of affected infants.  
 
Introduction 
 Tyrosine is a semi-essential amino acid that is used in the synthesis of 
catecholamines, thyroid hormones, and melanogenesis (1). The three sources of 
tyrosine are dietary protein, endogenous protein and hydroxylation of phenylalanine. 
Inborn errors in tyrosine catabolism occur on average at a rate of 1:120,000 (1) and 
are described in three types or five clinical forms. Tyrosinemia type Ia or hepatorenal 
tyrosinemia is primarily caused by a deficiency of the enzyme, fumarylacetoacetate 
hydroxylase (2), and can cause liver failure with cirrhosis and hepatic cancer, renal 
disease with hyphophosphatemic rickets and damage to peripheral nerves (1). A 
deficiency in maleylacetoacetate isomerare causes type 1b which causes similar 
kidney and liver failure and also progressive psychomotor retardation with death 
usually prior to one year (3). Tyrosinemia type II or oculocutaneous tyrosinemia is 
associated with corneal thickening and palmar and plantar hyperkeratosis caused by 
a deficiency of tyrosine aminotransferase (4). Problems with 4HPPD cause the two 
types of tyrosinemia type III (5). Type IIIa is caused by a primary defect in 4HPPD 
and can range in symptoms from minor to severe neurological abnormalities causing 
seizures, ataxia and mental retardation (6, 7). Hawkinsinuria or tyrosinemia type IIIb 
is due to abnormal function of 4HPPD causing metabolic acidosis and failure to 
thrive (8, 9).  
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Since treatment can prevent or reduce symptoms, many states screen for 
these inborn errors of metabolism of tyrosinemia I, II and III (IEMT) in newborns. 
North Carolina uses tandem mass spectrometry (MS/MS) to screen for over 30 
metabolic disorders. In North Carolina, tyrosine is one of the analytes with the 
greatest proportion of elevations on initial screens (10). Transient neonatal 
tyrosinemia (TNT) can be described as an abnormal elevation in blood tyrosine that 
peaks shortly after birth and usually resolves after 2-6 weeks of life (10, 11). It is the 
most common disorder of human amino acid metabolism. These transient elevations 
of tyrosine are thought to be due to inadequate activity of 4-hydroxyphenylpyruvic 
acid dioxygenase (4HPPD), an enzyme in the tyrosine degradation pathway (12). 
Since this disorder occurs more frequently in premature infants, it is thought 4-HPPD 
may not be fully active in TNT infants (11, 13). Other factors which have been 
mentioned as possible risk factors for TNT include a high protein diet and vitamin C 
deficiency (13).  
 TNT has long been considered benign and TNT neonates are usually 
considered clinically normal. However, as described earlier, untreated humans with 
IEMT frequently have severe neurological and developmental delays and other 
consequences as describe previously (1, 14). Brief periods of hypertyrosinemia may 
cause similar, but milder consequences. Treatment with ascorbate and low protein 
diets have been suggested to limit the impact of elevated tyrosine in the blood (13-
16).  
In the 1960s, the occurrence of TNT was reported at 30-50% of premature 
infants and 10% of term infants (17). At that time, infants were routinely given cow’s 
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milk, which has higher protein content and hence higher tyrosine than modern infant 
formulas or breastmilk (18). Now breastfeeding is the recommended and most 
common type of infant feeding, with 65% of infants having some duration of 
breastfeeding in 2001 national study (19). The alternative in healthy infants is non-
soy or soy formula. Despite the lower protein intake in newborns currently, TNT 
continues and now plagues newborn screening by causing a high false positive rate 
in the screening for IEMT. The high number of false positive screening results for 
IEMT has led to concerns about the continued impact of TNT.  In North Carolina, 
approximately 300 infants per year have elevated tyrosine, but over 99% of these 
infants will not be diagnosed with IEMT (10). High rates of false positives are of 
concern because it increases the number of repeat screenings needed with an 
associated increase in costs for medical care and laboratory expenses. The success 
in obtaining repeat screens is variable and taking a repeat screen may have 
negative psychological effects on parents and families (20, 21). Thus, finding criteria 
and procedures to reduce false positive screening results benefits both screening 
programs and families. Examining infant and maternal characteristics may provide 
further information about which infants manifest TNT (22). Therefore, this study 
analyzed newborn screening data to elicit possible risk factors associated with 
transient elevations in tyrosine.  
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Methods 
Study Population: 
Identified from infants born in North Carolina between January 1, 2000 and 
August 31, 2002 for whom a mandatory newborn screening was submitted to State 
Laboratory of Public Health (SLPH), the case group (n=918) consisted of all infants 
whose initial newborn screen had tyrosine elevations at H 300mg/dl and were not 
eventually diagnosed with the IEMT. One infant was excluded from this study 
because of the eventual diagnosis of tyrosinemia, type I. Controls (n=1383) were 
randomly selected from infants born in the same time period who had no metabolic 
abnormalities on their initial newborn screen to provide a 1:1.5 ratio of cases to 
controls. Infants were excluded if gestational age was less than 25 weeks or if 
information on gestational age, birth weight, gender or parity was missing (n=182). 
To ensure that the control group was representative of the general population of 
births in North Carolina, data available for public access on the North Carolina State 
Center for Health Statistics website were examined (23).  
 
Data Collection: 
 Newborn screening data were abstracted from the Laboratory Information 
Management System (LIMS) database of the North Carolina Newborn Screening 
Program at the State Laboratory of Public Health. The LIMS database included 
information provided by the specimen submitter via a data card containing infant 
demographics, medical information and maternal contact information which was 
attached to the filter paper containing the screening specimen, all initial and repeat 
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screening results, and an event log describing any follow-up activities. Additional 
information about an infant’s gestational age and parental demographic information 
was obtained by the matching of the newborn screening data to birth certificate data. 
The North Carolina State Center for Health Statistics processed this matching and 
over 99% of newborn screening records were successfully matched with birth 
certificate data. Those that did not match were dropped from the study. 
 
Study Variables: 
The dependent variable was tyrosine status as either normal or abnormal 
(elevated tyrosine H 300 mg/dl) on the infant’s initial newborn screen recorded in the 
LIMS database. Gender, age at screen (continuous in hours, dichotomous as < 72 
hours and H 72 hours), type of feeding (breastfed, formula fed, total parenteral 
nutrition (TPN) fed and combination fed) and race/ethnicity (Non-Hispanic White, 
Non-Hispanic Black and Non-Hispanic Other) were provided by the LIMS database 
as indicated on the newborn screening card. Infants were considered to be solely 
breast, formula, or TPN fed based on the feeding type noted at the time of newborn 
screen as indicated on the newborn screening data card. If more than one type of 
feeding was selected, then infants were considered to have combination feeding.  
Because of small sample size, Non-Hispanic American Indians, Non-Hispanic 
Asians, Non-Hispanic Hawaiian/Other Pacific Islanders were included as Non-
Hispanic Other along with those infants who had Unknown or multiple selections 
marked for their race. If ethnicity or race was missing from their newborn screening 
card (< 2% of infants), mother’s race and/or ethnicity from the newborn’s birth 
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certificate was used.  Likewise, gender was taken from birth certificate information if 
missing in newborn screening data. Gestational age (< 37 weeks, H 37 weeks), 
maternal age (< 20 years, H 20 years), maternal education (< high school, high 
school graduate, > high school) and parity (primipara, multipara) were provide by 
birth certificate data as continuous variables and created into categorical variables. 
 Small-for-gestational-age (SGA) was defined as infants whose birthweight 
was below the 10th percentile for similar infants of the same gestational age. For 
Hispanic infants, SGA was calculated using the algorithm created by Overpeck and 
colleagues (24) which required information on parity, infant’s gender, birth weight 
and gestational age. For Non-Hispanic infants, SGA was calculated using the 
algorithm created by Zhang and colleagues (25) which required information on 
parity, infant’s gender, birth weight, gestational age and race. For the latter 
algorithm, race-specific information on Asian, American Indian and other/mixed race 
were not available so the algorithm for white infants was utilized since the mean birth 
weight of these term infants were most similar to those of the white infants.  
 
Statistical Analysis: 
Data analysis was performed using STATA v8. Characteristics of the study 
population were examined. Crude bivariate analysis examined potential associations 
between abnormal tyrosine and potential risk factors. Due to the potential effect 
modification of being preterm (liver immaturity), the model was stratified by preterm 
and term infants.  Stratum-specific odds ratios were examined for substantive 
differences to find potential interactions. Potential interaction effects were examined 
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using the Breslow-Day Test for Homegenity with inclusion criteria of p< 0.10. 
Because of the exploratory nature of this study, the effects of all variables were 
evaluated by inclusion in the final regression model. Logistic regression analysis was 
used to estimate the odds of TNT and 95% confidence intervals (CI) associated with 
each covariate adjusted for all others.  
Analysis of Change in Abnormal Tyrosine Cutoff: 
Beginning September 1, 2002 the NC Newborn Screening Program raised the 
cutoff for abnormal tyrosine from H 300 mg/dl to H 500 mg/dl. This study was 
concerned with all elevations in tyrosine, but availability of data was restricted to 
those appearing as “abnormal” in the Newborn Screening Database. To provide 
information that reflected this change in the “abnormal” criteria, a second case group 
(n=233) was created from infants born January 1, 2000 through December 31, 2003 
who had elevated tyrosine of H 500 mg/dl (See Appendix 2). Since the results in this 
second case group were similar to the results found in the case group using the H
300 mg/dl cutoff, this paper focuses on the latter cutoff of H 300 mg/dl. Because 
infants with tyrosine < 500 mg/dl have been diagnosed with IEMT in other states, I 
felt this it was appropriate to use the H 300 mg/dl cutoff. In addition, to further 
explore whether the level of tyrosine elevation affected the associations with risk 
factors, ordered logistic analysis was used to consider varying ranges of elevated 
tyrosine. Since no significant associations were found, the simpler model using a 
binary description of elevated tyrosine was used. (data not shown) 
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Results 
 The characteristics of the cases (n=918) and controls (n=1383) are presented 
in Table 5.1. The control group had comparable proportions of gender, ethnicity, and 
gestational age as the total population of births in North Carolina for 2002 (data not 
shown), suggesting success in random selection of controls. Infants with abnormal 
tyrosine were more likely to be preterm (53%) and SGA (18%) than control infants 
with normal tyrosine (10%, 10%). The distribution in racial and ethnic groups varied 
by tyrosine status  with cases having lower proportion of Non-Hispanic Whites (46%) 
and higher proportion of Hispanics (18%) compared to controls (60%, 10%). While 
the proportion of breast fed infants was similar, a lower proportion of infants with 
abnormal tyrosine were formula fed (17%) compared to controls (32%).  Maternal 
characteristics of age and parity appeared fairly similar between cases and controls.  
 When adjusting for the other risk factors (gender, SGA, multiplicity, maternal 
age, parity, feeding, gestational age), Non-Hispanic Black infants (AOR= 1.6, 95% 
CI 1.3, 2.1) and Hispanic infants of any race (AOR=2.6, 95% CI 1.9, 3.5) were more 
likely to have elevated tyrosine compared to Non-Hispanic White infants (Table 5.2). 
Being small for gestational age was associated with elevated tyrosine (AOR=2.4, 
95% CI 1.8, 3.2). Later age at specimen collection also increased the risk for 
elevated tyrosine (AOR=2.8, 95% CI 1.8, 4.5). Maternal factors had a slight 
association (teen mom AOR=1.7, 95% CI 1.2, 2.3; multipara AOR=1.9, 95% CI 1.5, 
2.4), but were smaller in magnitude when compared to the effect of preterm, feeding, 
SGA and race/ethnicity.  Gender and multiple births were not associated with 
elevated tyrosine. 
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 Preterm birth was a major risk factor for elevated tyrosine. Crude analysis 
showed that preterm infants were 9.7 times more likely to have elevated tyrosine 
when compared to term infants (Table 5.1). Gestational age was found to modify the 
effect of feeding and elevated tyrosine. Joint effect categories representing each 
combination of preterm/term with each of the four types of feeding were used to 
model the interaction of gestational age and type feeding (Table 5.3). Compared to 
term infants who were formula fed, preterm infants on all types of feeding had very 
high odds of abnormal tyrosine with AOR ranging from 27 to 63.  Term infants who 
consumed breastmilk (AOR=6.0, 95% CI 4.1, 8.6), TPN (AOR=6.9, 95% CI 2.9, 
16.5) or combination of feeds (AOR=4.0, 95% CI 2.5, 6.5) had a greatly increased 
risk when compared to formula fed term infants. When compared to preterm infants 
who were formula fed, neither breast feeding nor combination feeding had an effect 
on elevated tyrosine among preterm infants (data not shown). 
 
Discussion 
 In accordance with the suggestion of many studies that TNT is primarily a 
condition in preterm infants (13, 26, 27), being preterm was the strongest risk factor 
for TNT in this study. However, this study found a surprising presence of TNT in 
term infants. Being Hispanic, Non-Hispanic Black, SGA, having a teen mother and 
being a multipara birth were also risk factors among all gestational ages. In term 
infants, breastfeeding was a strong predictor of TNT. 
 When examining the effect of feeding among premature infants, we see that 
the type of feeding is no longer significant which suggests that being preterm has a 
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greater effect than type of feeding. This effect may be due to the immature 4-HPPD 
enzyme that has not yet reached full functionality due to decreased time of gestation 
(1, 11, 13). Similarly SGA infants have not reached the developmental gains despite 
their actual gestational age compared to normal for gestational age infants. Thus, 
this issue of an immature enzyme may also be reflected in the increased risk of TNT 
among SGA infants. Because the biological explanation of an immature enzyme is 
less likely to account for TNT once an infant has reached term gestational age, it is 
interesting that among term infants, there are still high rates of TNT. Among cases, 
forty-seven percent had a gestational age of greater than thirty-seven weeks.  
In term infants, the effect of feeding is particularly striking. Previous studies 
had suggested that the high rates of TNT was due to the use of cow’s milk for infant 
formula and that as breastfeeding rates increased, this phenomenon would 
decrease (11, 16, 28). Despite modern changes in infant feeding and increased 
rates of breastfeeding (18), transient elevations in tyrosine continue to be an issue in 
newborn screening. In fact, this study showed that term breast fed infants have six 
times the odds of having elevated tyrosine compared to term formula fed infants. 
This is unexpected when looking at the nutrient content of formula, as it has higher 
amounts of protein and tyrosine than breast milk. However, since the recommended 
age of newborn screening is 48-72 hours, it is likely that breast fed infants are still in 
a catabolic state due to limited breast milk output and associated weight loss seen in 
breast fed infants during the first few days of life (29). Thus, the elevated tyrosine in 
these infants may be due to more endogenous than exogenous sources of tyrosine. 
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 Infants on TPN also have higher odds of abnormal tyrosine, but it is difficult to 
determine if this effect is due to the actual composition of TPN or other factors 
associated with why an infant may be on TPN. Since most formulations of TPN have 
very little to no tyrosine included, it is more likely this effect is representing other 
factors such as illness, surgery, stress and other factors not evaluated in this study 
which may contribute to catabolism. In addition, cell sizes for TPN were small. Thus, 
wide confidence intervals were seen around the effect estimate, casting doubt on 
their reliability as a true estimate. Similarly, the effect shown for infants who had 
mixed sources of feeding is difficult to interpret clinically as there are many possible 
combinations and proportions. 
 There also appears to be a relationship between ethnicity and elevated 
tyrosine. Hispanic infants are at higher risk of having elevated tyrosine. In North 
Carolina, this phenomenon of higher rates in the Hispanic population has also been 
seen in propronylcarnitine (C3), an analyte used in the screening for methylmalonic 
acidemia and propionic academia. About 40% of infants with elevated C3 are 
Hispanic, a group comprising approximately 15% of the state birth rate in North 
Carolina (10). It is not uncommon for different incidences of metabolic disorders to 
be seen among different populations. However, available data is unable to 
distinguish whether this difference is a genetic or a cultural difference in feeding. 
 Transient elevations of tyrosine in newborns can be looked at in two ways. 
First, it can be considered as a problem in screening for IEMT. Each abnormal test 
requires notification of physicians and families and an additional newborn screen to 
be collected and analyzed. This can be stressful for families (21) and adds additional 
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financial costs to the state. The different risk factors for TNT can be considered 
when counseling families when repeating a newborn screen to better describe the 
potential risk for IEMT and ease parental stress. Also, it may be useful to create 
additional criteria to define abnormal tyrosine. For example, a different cutoff could 
be established for breast fed versus formula fed infants or Hispanic versus Non-
Hispanic infants. This would provide ways to fine tune screening and reduce false 
positive results. This study was unable to compare infants with TNT to infants with 
IEMT because of the low number (n=1) of infants with IEMT during the study period. 
Future studies that compare infants with TNT to infants with IEMT are necessary to 
further inform the appropriateness of these alternative criteria. 
 Secondly, we should consider if transient elevations of tyrosine have any 
clinical significance. Animal studies have shown that elevated blood tyrosine can be 
noxious to the developing nervous system of infant rats (30). Previous studies have 
suggested a negative impact on long term educational outcomes and development 
(31, 32). Two case reports and series have noted lethargy, reduced motor activity 
and corneal opacities in the neonatal period (33, 34). In a study comparing 7-9 year 
old children who had presented with TNT as neonates and had elevations for over 
16 days (n=27) to control children, Rice and colleagues (31) found transient high 
levels of tyrosine elevation to be associated with decreased performance on tests of 
cognitive ability. Similarly, Jardim and colleagues (35) evaluated children at age 4 
years who had presented with TNT as newborns and found slight intellectual deficits 
in these children compared to controls. Other studies have looked at intellectual 
deficits in early childhood with inconsistent findings, causing controversy over 
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whether TNT is benign (31, 32, 35-38). It is interesting to note that in the studies with 
null findings, the authors often recommended that infants with TNT receive treatment 
(low protein diet with vitamin C supplementation) although this is not current clinical 
practice (36-38).  
The present study takes a cross-sectional look at elevated tyrosine in 
newborns. Unlike many previous studies which consisted of case reports, this study 
takes a population perspective to examine TNT. Further research is needed to 
investigate whether the concentration of tyrosine and the duration of its elevation 
have a direct effect on infant health and neurological outcomes. This information 
could help inform treatment and determine whether tyrosine levels should be 
decreased more rapidly in the neonatal period.  
 This study examines one of the challenges facing expanded newborn 
screening. NC was one of the first states to expand their newborn screening 
program using tandem mass spectrometry and provides a unique opportunity to re-
examine TNT at a population level. As we were able to examine all infants born in 
North Carolina with abnormal tyrosine during the study period, this study had a large 
case size considering the rarity of abnormal metabolites and metabolic disorders. 
Because of the relative newness of this expanded program, we were unable to 
compare infants with transient tyrosine elevations to infants who have IEMT. In 
North Carolina, only two infants were diagnosed with IEMT through tandem mass 
newborn screening during the study period. A larger population of infants across the 
country is needed to evaluate the differences between IEMT and TNT. Another 
limitation is that this study relies on the accuracy of information provided by the 
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submitter of the newborn screening specimen and birth certificate data. While these 
sources of information are a common way to collect data, it may not be as reliable as 
collecting this study information directly from families. However, direct collection may 
not be the most efficient uses of resources and are affected by their own issues such 
as recall bias. Acknowledging these limitations, this study provides new information 
about TNT and provides important information for newborn screening programs 
looking to refine tyrosine screening to better serve families. 
 In summary, transient elevations of tyrosine in newborns continue to be an 
issue that plagues expanded newborn screening. This study suggests that adding 
further criteria beyond just the analyte level may help to limit the number false 
positive results in screening for IEMT. Since TNT has continued to be observed 
despite changes in feeding practices, it would be helpful to further explore this 
disorder as well as the need to use treatment to more rapidly lower plasma tyrosine. 
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Table 5.1 Infant and Maternal Characteristics of Cases and Controls and the 
Unadjusted Association of Each Characteristic with Abnormal Tyrosine 
 Risk Factors Cases n (%) 
Control 
n (%) 
Crude OR  
(95% CI) 
Tyrosine Screening Status  
Abnormal Tyrosine (H 300 mg/dL) 918 (40%) -  - 
 Normal Tyrosine (< 300 mg/dL) - 1383 (60%)  - 
Demographic 
Gender    
 Male 431 (47%) 711 (51%) 1.0 
 Female 487 (53%) 672 (49%)  1.2 (1.0, 1.4) 
Race / Ethnicity    
 Non-Hispanic White 423 (46%) 832 (60%) 1.0 
 Non-Hispanic Black 264 (29%) 341 (25%)  1.5 (1.2, 1.8) 
 Non-Hispanic Other  69 (8%) 70 (5%)  1.9 (1.3, 2.8) 
 Hispanic 162 (18%) 139 (10%)  2.3 (1.8, 3.0) 
Gestational Age (weeks)* x = 35.3 [3.8] x = 38.7 [1.9]  -
Term (H37 wks) 431 (47%) 1239 (90%) 1.0 
 Preterm (<37 wks) 487 (53%) 144 (10%)  9.7 (7.8, 12.2)
Small for Gestational Age (SGA)    
 Not SGA 749 (82%) 1251 (90%) 1.0 
 SGA 169 (18%) 132 (10%)  2.1 (1.7, 2.8) 
Age at Screen Collection (hr)* x = 48.2 [32.7] x = 38.4 [28.9]  -
T 72 hours 793 (87%) 1333 (97%) 1.0 
 >72 hours 119 (13%) 37 (3%)  5.4 (3.7, 8.1) 
Birth Weight (grams)* x = 2479 [832.8] x = 3297 [594.8]  -
Multiple Birth    
 Singleton 803 (87%) 1339 (97%) 1.0 
 Multiple 115 (13%) 44 (3%)  4.4 (3.0, 6.4) 
Feeding Type  
Breastmilk, exclusive 509 (55%) 750 (54%) 1.0 
 Formula, exclusive 154 (17%) 441 (32%)  0.5 (0.4, 0.6) 
 TPN, exclusive 101 (11%) 33 (2%)  4.5 (3.0, 7.0) 
 Combination Feeding 154 (17%) 159 (12%)  1.4 (1.1, 1.8) 
Maternal Characteristics 
Maternal Age* x = 26.1 [6.1] x = 26.8 [6.0]  -
Adult Mom (H20 yrs) 779 (85%) 1214 (88%) 1.0 
 Teen Mom (<20 yrs) 139 (15%) 169 (12%)  1.3 (1.0, 1.6) 
Parity    
 Primipara 295 (32%) 572 (41%) 1.0 
 Multipara 623 (68%) 811 (59%)  1.5 (1.2, 1.8) 
* x = Mean [Standard Deviation] 
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Table 5.2 Adjusted Odds† and 95% Confidence Intervals for the Risk of 
Abnormal Tyrosine Screen by Risk Factor 
 Risk Factors AOR  95% CI 
Demographic 
Gender   
 Male 1.0   - 
 Female 1.2   1.0, 1.5 
Race / Ethnicity   
 Non-Hispanic White 1.0 - 
 Non-Hispanic Black 1.6 1.3, 2.1 
 Non-Hispanic Other  2.4 1.6, 3.7 
 Hispanic Any Race 2.6 1.9, 3.5 
Small for Gestational Age   
 Not SGA 1.0 - 
 SGA 2.4 1.7, 3.2 
Patient Age at Screen Collection   
 T72 hours 1.0 - 
 >72 hours 2.8 1.8, 4.5 
Multiple Birth   
 Singleton 1.0 - 
 Multiple 1.1 0.8, 2.7 
 
Maternal Characteristics 
Maternal Age   
 Adult Mom (H20 yrs) 1.0 - 
 Teen Mom (<20 yrs) 1.7 1.2, 2.3 
Parity   
 Primipara 1.0 - 
 Multipara 1.9 1.5, 2.4 
†Each risk factor adjusted for other factors in table and gestational age and feeding 
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Table 5.3 Adjusted Odds† and 95% Confidence Intervals for the Risk 
Associated with Type of Feeding on Abnormal Tyrosine Screen Conditional on 
Gestational Age  
 Feeding Type AOR 95% CI 
Preterm: Formula, exclusive 26.8  16.9, 44.8 
Breastmilk, exclusive 37.8     24.0, 59.6 
 TPN, exclusive 62.5     33.2, 117.5 
 Combination 39.4     21.9, 71.0 
 
Term: Formula, exclusive 1.0        - 
 Breastmilk, exclusive 6.0       4.1, 8.6 
 TPN, exclusive 6.9       2.9,16.2 
 Combination 4.0       2.5, 6.5 
† Adjusted for gender, race/ethnicity, size-for-gestational-age, multiplicity, maternal age, and parity. 
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CHAPTER 6 
 
CONCLUSION 
 
Summary of Research Findings and Public Health Implications 
The goal of this dissertation was to examine three issues that have arisen 
from expanded newborn screening for inborn errors of metabolism.  The first topic 
(Chapter 3) was the follow-up of borderline abnormal newborn screening results and 
risk factors associated with lack of repeat screen submission. Then, findings were 
presented on pediatrician knowledge, clinical practices and beliefs in the utility of 
metabolic newborn screening (Chapter 4). Finally, risk factors for transient neonatal 
elevation of tyrosine were presented (Chapter 5). To examine these topics further, a 
summary of key findings for each study are presented and public health implications 
are discussed. 
 
Borderline Abnormal Screen Follow-up: 
 In Chapter 3, the procedures for borderline abnormal screen follow-up, the 
rate of repeat screen submission, and the individual- and community-level predictors 
for lack of repeat screen submission were evaluated. Of infants with an initial 
borderline abnormal newborn screen, approximately nine percent of infants never 
had a repeat screen submitted. While a small proportion, these infants have been 
identified through the initial screen as being at a higher risk for having an IEM. When 
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examining infant, maternal and community characteristics using logistic regression 
analysis adjusted for clustering by community, infants who were Hispanic, Black or 
who lived in the a neighborhood with a low socio-economic (SES) index were less 
likely to have had a repeat screen submitted than infants who were Non-Hispanic 
White or from neighborhoods with the highest SES index. These findings reflect 
difficulties associated with access to health care by minorities and those living in 
poverty in the United States (1-3). After identifying populations who were at higher 
risk of an incomplete follow-up, newborn screening programs can consider 
strategies to better address the needs of these at-risk populations.  
A current strategy to prompt repeat screen submission, beyond providing the 
screening report to physicians, is a letter notifying mothers of an abnormal screen 
that is sent by confirmed receipt mail if no repeat screen is received by the state lab 
within fourteen days of pediatrician notification. This study has shown that this 
parental letter was positively associated with repeat screen submission. Since only 
an English version of this letter was routinely sent and because the Hispanic 
population is at greater risk of loss to follow-up, one strategy would be to send a 
bilingual letter in English and Spanish to better reach the portion of the Hispanic 
population that is non-English speaking. In fact, after presenting these research 
findings to the North Carolina Newborn Screening Advisory Board, a bilingual letter 
was proposed. Another issue with this parental letter was that it was often not 
delivered due to problems with maternal contact information, a problem more 
frequent among Hispanic and Black families. This study could not evaluate the exact 
reasons for families not receiving the parental letter such as whether the family had 
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moved or were not asked to verify their address. Encouraging the specimen 
submitter to verify the maternal contact information or allowing space for an 
alternative contact for use when a letter is undeliverable may be other strategies to 
ensure follow-up contact.  
Another strategy to increase repeat screen submission may be to utilize 
community-based follow-up, a strategy which has been highly effective for the 
state’s Sickle Cell Screening Program. With the community-based approach, when a 
repeat screen is not submitted within two weeks of the parental letter being sent 
(four weeks after the initial abnormal notification), a representative would seek out 
these infants in the community and personally discuss with them the need to have a 
repeat screen and/or assist them in this process. Since the number of infants who 
would require this extra level of follow-up is relatively small (approximately forty per 
year), this community-based follow-up would be feasible as shown by the Sickle Cell 
Program.  
Additionally, increasing the level of awareness in the general population about 
newborn screen may also benefit newborn screening follow-up. Better public 
education about newborn screening may not only involve parents more in this 
mandated medical process but also encourage parents to be more proactive in 
seeking screening results. Considering follow-up strategies such as these or others 
could further improve the efficiency of collecting a repeat screen and the overall 
effectiveness of the program. Once the decision has been made to universally 
screen newborns for IEM, it is the responsibility of the program to not only obtain the 
initial screening, but to follow-up as well. As stated by the American Academy of 
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Pediatrics, “Newborn screening is more than testing - it should always be part of a 
system that includes screening tests, follow-up, diagnosis, treatment, and evaluation 
as necessary. The primary objective of each state's newborn screening system 
should be to ensure that every newborn receives appropriate and timely services” 
(4). 
 
Physician Survey: 
In Chapter 4, pediatricians’ knowledge of the North Carolina newborn 
screening policies, their clinical protocol for handling newborn screening results and 
their personal beliefs about the utility of newborn screening were evaluated using a 
self-administered anonymous paper survey administered at North Carolina Pediatric 
Society (NCPS) Meetings. Approximately half of the pediatricians felt that they had 
low levels of knowledge about newborn screening procedures and had low levels of 
comfortable explaining newborn screening results to families. In fact, over forty 
percent of pediatricians did not correctly respond to more than three of the seven 
questions about newborn screening and North Carolina policy. In addition, some 
clinical practices did not follow the desired protocol such as communicating normal 
as well as abnormal results to families, having a pediatrician rather than a clerk 
inform families when results are diagnostically abnormal, ensuring that pediatricians 
have reviewed screening results for all of their infant patients, and not assuming 
results are normal if the pediatrician has not heard otherwise.  
While this study had a small sample size and generalizability limited to the 
NCPS meeting attendees, it may be expected that pediatricians attending 
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information-based meetings may be more knowledgeable than non-attendees and 
thus, the need for pediatrician education about newborn screening may be even 
greater than found in this study. From survey responses on useful educational tools, 
a preference was seen among North Carolina pediatricians for tools with wide-
spread access such as the North Carolina Pediatrician and NCPS or SLPH website. 
A lower preference was seen for traditional means of education such as 
informational booklets, lectures and grand rounds. One strategy to consider is a 
web-based module on newborn screening that includes North Carolina procedures 
and reviews disorders now included in the expanded screening panel. This module 
could be accessed through the NCPS or SLPH website and be easily disseminated 
for use in other education settings such as in North Carolina medical schools. Since 
the SLPH website is one of the main tools a pediatrician uses to access screening 
results, another approach could be to add an interactive aspect of the website to 
post reminders and facts on newborn screening that are viewed each time a 
pediatrician accesses the website. These methods could take advantage of 
technology that allows timelier and wide-spread means to provide education on 
standard and new policies surrounding state newborn screening. 
Future studies that examine a study population with state-wide representation 
could better assess the unmet education needs and provide more direction on where 
to focus education. In addition, after considering findings in Chapter 3 on abnormal 
screen follow-up and reviewing responses to the current survey in Chapter 4, there 
are other topics which would be of interest to assess. For example, it would be 
interesting to learn if pediatricians realize that they have been found liable for the 
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follow-up of newborn screening results when they are identified as the health care 
provider on the newborn screening card, to find out where or how they learned about 
newborn screening (e.g. self-taught, medical school, etc.) and more about 
interactions that occur with families when relaying results. A better understanding of 
pediatricians’ knowledge and practices is essential in identifying potential areas that 
need improvement in order to ensure that the system is working efficiently as 
possible to prevent missing affected infants and improve communication between 
the screening program, pediatricians and families. 
 
Transient Neonatal Tyrosinemia: 
In Chapter 5, risk factors for transient neonatal tyrosinemia were examined. It 
is important to better understand not only as a condition itself, but also because of 
TNT’s positive association with high rate of false positive screens for the inborn 
errors of tyrosine metabolism (IEMT). As expected, being preterm or small for 
gestational age were very strong predictors of TNT. This finding has been well 
documented in the literature (5, 6) and is considered to be due to an immature 
enzyme in tyrosine metabolism. Although not as strong, being Hispanic or Black, 
having a teenage mother, or being a multipara birth were also risk factors for TNT 
among all gestational ages. Contrary to previous findings, term breastfed infants 
were at a much higher risk for TNT than formula fed infants. A hypothesis for this 
finding is that breastfed infants are still in a catabolic state due to limited breastmilk 
output and associated weight loss at the time of screening, 24-72 hours of age, and 
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the higher endogenous protein increases the tyrosine load that the limited enzyme 
can process. 
This study is important because it revisited a condition on which little research 
has been done in recent years, and which, despite the expectation of a decline in 
prevalence with changes in infant feeding practices, still continues to be a neonatal 
issue. A goal of this research was to redefine criteria in determining what should be 
considered an “abnormal” tyrosine concentration on a newborn screen. Two main 
problems exist in using only the information from this study to make direct 
suggestions on how to restructure the interpretation of tyrosine results. One issue is 
that among the identified risk factors there was not a clear association with the level 
of tyrosine. For example, it was clear that being preterm was a risk factor for 
elevated tyrosine, but there was not a linear relationship in gestational age and 
tyrosine value. Therefore, we are unable to make a direct suggestion that preterm 
infants should have a higher cutoff value to be considered abnormal. It may be 
possible to suggest that preterm infants with any borderline (not diagnostic) 
abnormal tyrosine screen should not be considered abnormal, but this leads in to the 
second issue. This study compared TNT infants to infants with no abnormalities in 
the newborn screen. This is important to better understand what makes an infant 
prone to TNT, but to be confident in changing criteria, we need to know if these risk 
factors also differentiate between infants with TNT versus infants with IEMT. In order 
to accomplish this task, a nationwide study needs to be initiated in order to provide a 
sufficient number of infants who have been diagnosed with IEMT. However, until 
further studies have been done, the risk factors identified in this study can be useful 
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in counseling families who have been informed that their infant has abnormal 
tyrosine on their newborn screen. When discussing the need for a repeat screen and 
the possibility of IEMT diagnosis, clinicians can reassure families that if their infant 
was preterm, SGA, breast-fed or Hispanic, that it may be likely that this was a false 
positive result. Since learning of an abnormal screen can be stressful for families (7), 
the information from this study can provide evidence to discuss with families and 
may reduce some of this associated stress. Outside of newborn screening, this 
study provide further understanding of this neonatal condition and draws attention to 
its continued presence and the need for future studies to better understand long-
term consequences on infant health and development.   
 
Study Limitations 
For the newborn screening-based studies in Chapters 3 and 5, a limitation is 
that the studies rely on the accuracy of the information recorded by the submitter of 
the newborn screening record or birth certificate which may not be as reliable as 
collecting information directly from families. In addition, the variables that could be 
considered were restricted to those available from the data sources and only in the 
form provided. For example, more detailed medical history about the infants could 
not be considered in examining TNT nor could variables such as type of feeding be 
assessed beyond the selection marked on the newborn screening card for that 
particular time. Because these two studies focused on population data sources, 
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some individual level data was not available such as the reason a parental letter was 
not delivered or information to determine family SES.  
In Chapter 4 (Survey of NCPS Pediatricians), the main limitations were the 
small sample size and limited generalizability. Health care professionals, such as 
pediatricians, are difficult to sample due to high demands on their time so a major 
problem in surveying pediatricians is the traditionally poor response rate. This study 
had a similar response rate of approximately 30% as another survey (8) of 
pediatricians and newborn screening. Because of convenience and lower expense, 
a non-random sample was used in this study. A preferred method would have been 
to randomly sample from all pediatricians and family practice physicians in the state. 
Pediatrician knowledge was the main focus of the survey so bias can arise from 
using continuing education meetings to elicit study participants. People who attend 
information-based meetings, such as those organized by NCPS, may be more 
knowledgeable than non-attendees and among attendees, those who complete the 
survey, may be more motivated or interested in the topic and thus, more 
knowledgeable. It is likely that these results overestimate the knowledge of the 
general population of North Carolina pediatricians. Respondents were fairly similar in 
their geographic locations as non-responders so the responses in this survey may 
represent all pediatricians who attended these NCPS meetings. Other information 
not available about non-responders would allow for better analysis of bias and 
representation. However, surveying health care professionals is an important 
method in health services research for improving understanding of attitudes and 
practices. 
107 
Study Strengths 
This dissertation contributes to the field of IEM and newborn screening by 
examining topics not thoroughly researched in the literature. In the newborn 
screening studies of Chapter 3 and 5, the use of population-level data allowed for 
large case sizes, considering the rarity of abnormal metabolites and IEM. By linking 
newborn screening data to other population data sources such as birth certificates 
and census data, maternal and community information were considered in addition 
to infant data which created a larger picture for the studies. This was especially 
important in the study on TNT (Chapter 5) as gestational age was only available 
from birth certificate data and played an important role in the modeling and 
understanding of this condition. In the abnormal screen follow-up study (Chapter 3), 
multi-level modeling allowed both individual- and community-level characteristics to 
be considered. In addition, the use of geographic data allowed for a visual depiction 
of the study population, the ability to consider distance to provider as a potential 
issue in health care access, and the linkage to community-level data. In the survey 
of NCPS pediatricians (Chapter 4), an important partner in the newborn screening 
program was examined. No known studies have examined pediatricians’ clinical 
practices with newborn screening or taken a close look at their understanding of 
screening procedures. Since this study was a new area of investigation, the 
convenience sample served the purpose of developing new hypotheses and 
generating more information before investing resources into a larger sampling 
approach.  
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Conclusions 
This dissertation examined three salient public health issues that have 
emerged for the expanded North Carolina Newborn Screening Program. North 
Carolina was the first state to expand newborn screening for inborn errors of 
metabolism (IEM) and screen for over 25 disorders using tandem mass 
spectrometry (MS/MS). This expansion has further increased the ability of this public 
health program to limit the morbidities and mortality associated with delayed 
diagnosis of IEM. However, new issues have arisen that coincide with the increased 
complexity of expanded screening and follow-up. Because of the higher number of 
disorders screened for in expanded newborn screening, there are a greater number 
of abnormal results that require follow-up and a repeat screen. Evaluating the ability 
of current procedures to respond to abnormal results has important policy 
implications for ensuring that North Carolina infants are not lost to follow-up and to 
prevent or reduce morbidities and mortalities associated with delayed treatment. 
Results from this study can inform recommendations for improvements in the follow-
up procedure used in North Carolina. Recognizing individual or community factors 
that increase the risk for not receiving a follow-up screen is important for 
recommending policy changes to meet the needs of these at-risk populations. 
Similarly, pediatricians are expected to screen, follow-up and communicate with 
families about newborn screening making them crucial to the success of the 
program and in the follow-up of abnormal screens. With the increased number of 
metabolites and disorders of which to be aware, consideration should to be given to 
the need to keep pediatricians updated and comfortable with their involvement in 
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expanded screening. Likewise, understanding more about infants characteristics that 
are associated with high false-positive screening rates such as tyrosine provide a 
better understanding of this neonatal condition, can help clinician be aware infant 
characteristics that make it more likely that their abnormal screen is a false positive, 
and provide evidence to combine with future research to consider other markers to 
limit who is considered to have an abnormal screen, thus limiting the number of 
repeat testing, reduce financial costs and reduce family stress. Taking a closer look 
at these areas is not only important for the North Carolina Newborn Screening 
Program but also can provide information for other states to consider as they expand 
their own programs. Overall, this research will directly benefit North Carolina’s 
Newborn Screening Programs by providing data to consider policy changes and 
state-wide educational needs to improve the efficiency and effectiveness of the 
program. 
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APPENDIX 1: 
 
SURVEY OF PHYSICIAN KNOWLEDGE, CLINICAL PRACTICES AND BELIEFS 
ON NEWBORN SCREENING OF INBORN ERRORS OF METABOLISM 
 
In August 1997, North Carolina Newborn Screening Program added tandem mass spectrometry at the State Laboratory Public Health (SLPH)
to screen for more than 20 additional inborn errors of metabolism (metabolic newborn screening).  The technique can detect elevations of 
certain amino acids, which may be suggestive of certain amino acidopathies, and of acyl carnitines, which may be elevated in certain fatty acid 
oxidation disorders and organic acidemias.  Results from metabolic screening are relayed to the primary care physician by report for both 
abnormal (borderline or diagnostic) and normal results.  In addition, there is an immediate telephone call for all diagnostic abnormals. 
 
(Please check one unless otherwise indicated) 
A. The following questions concern your current protocol involving metabolic newborn screening: 
1. On average, how many new infants (after discharge from the newborn nursery) do you see per week?
 None (If none, please skip to Question 11)
 <5 
 5-10 
 > 10 
 
2. In your practice, do you personally review newborn screening results?   Yes   No  
3. Do you or your staff access newborn screening results from the SLPH newborn screening website?    Yes   No 
 
4. If you have not received a newborn screening report for a new patient by the time of the initial visit, do you: 
 Assume the screening results were normal 
 Contact the SLPH by telephone or FAX 
 Re-test the infant 
 Check SLPH newborn screening website      
 Other (specify)__________________________________________________ 
 
5. If the metabolic newborn screening results are normal, is this information relayed to the parents?   Yes   No 
 
6. If the metabolic newborn screening report indicates an borderline abnormal result, do you: 
 Re-test at the next regular visit 
 Contact family and schedule an immediate clinic visit for re-test 
 Other (specify)__________________________________________________ 
 
7. Have you ever had a patient with an abnormal metabolic newborn screen?  Yes   No 
 
8. How comfortable do you feel in explaining an abnormal metabolic newborn screen to families? 
 Very uncomfortable 
 Uncomfortable 
 Comfortable 
 Very comfortable  
 Comfort depends on the abnormal metabolite 
 
9. If you are called because an infant has very elevated metabolites (diagnostic abnormal) on a metabolic newborn 
screen, the family would be contacted by: 
 Clinic support staff 
 Physician or RN/FNP/PA 
 RN/FNP/PA always 
 Physician always 
 
10. Have you ever had a patient with an abnormal metabolic newborn screen who was then diagnosed with the disorder 
after confirmatory testing?    Yes   No 
 
B.  The following questions refer to policy for the Newborn Screening Program in North Carolina: 
11. What is the recommended age for taking the first newborn screening blood specimen be taken? 
 0-24 hours 
 24-47 hours 
 48-72hours 
 >72 hours 
 Unsure 
 Other (specify)__________________________________________________ 
 
12. If an infant is discharged from their place of birth prior to the recommended age for screening, the blood specimen 
should be collected: 
 Prior to discharge even though the age is earlier than recommended 
 At the first well-baby visit 
 Other (specify)__________________________________________________ 
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13. If an infant has an abnormal metabolic newborn screen and no repeat specimen is received within 14 days, the SLPH:
 Contacts the infant’s physician 
 Sends confirmed delivery mail to the mother and physician  
 Pursues no further 
 Unsure 
 
14. Who pays for confirmatory testing after abnormal metabolic newborn screens?  
 State Lab Public Health 
 Third party payers 
 Ordering physician / family 
 No charge 
 Unsure 
 
15. The goal of newborn screening is to: (Please select ALL that apply) 
 Confirm the diagnosis of a metabolic disorder 
 Identify infants with treatable disorders pre-symptomatically 
 Identify infants with treatable disorders once they become symptomatic 
 Identify infants early to prevent or limit mortality/morbidity 
 
16. You saw a 9-month old for the first time because they have moved here from another state. The child has a symptom 
of a metabolic disorder (e.g. a strong maple syrup odor, possibly indicating Maple Syrup Urine Disease). Why won’t 
the SLPH newborn screening laboratory run a blood spot from this child?   
 Child is from another state  
 Child is beyond the age the lab will screens 
 MSUD can’t be detected 
 Unsure 
 Other (specify)__________________________________________________ 
 
17. You recently saw a newborn who was doing well, but shortly after, you receive a call that this infant has an 
abnormal metabolite on their metabolic newborn screen (e.g. glutaryl carnitine which is elevated in Glutaric 
Acidemia Type I).  Would you be concerned?  Yes   No 
 
18. How knowledgeable do you feel about the procedure for metabolic newborn screening (including follow-up)? 
 Not knowledgeable 
 Somewhat knowledgeable 
 Knowledgeable 
 Very knowledgeable  
 
C. Please provide your opinion on the following questions: 
19. In your opinion, should the newborn screening panel include… 
a. Disorders with neonatal onset of symptoms?   Yes    No 
 
b. Disorders with adult onset of symptoms?   Yes    No 
 
c. Conditions which are not currently treatable but identification would provide information for parents to 
plan for future pregnancies?   Yes    No 
 
20. Please check the disorders for which you feel it is appropriate to screen newborns. 
 Phenylketonuria (PKU)   Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) 
 Huntington Disease    Cystic Fibrosis (CF) 
 Chromosomal Disorders   
 
21. What educational tools would be helpful in keeping you informed about the Newborn Screening Program? 
 (Please check all that apply) 
 Articles in the North Carolina Pediatrician  CME lectures   
 SLPH or North Carolina Pediatric Society website links  Grand rounds 
 Informational booklets       Other (specify)______________________ 
 
D. Demographic information: 
 22.  Gender:  Male   Female 
 
23.  Year of medical school graduation: __________  
 
24.  Type of practitioner:  Pediatrician   Family Practitioner   Other (specify): ____________________________ 
 
25.   Type of practice:   Solo/Private      Group        Other (specify): ____________________________________ 
 
26.  Location of medical practice:  City___________________________ County________________________________
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APPENDIX 2: 
 
SUMMARY OF FINDINGS OF RISK FACTORS FOR TRANTSIENT NEONATAL 
TYROSINEMIA FOR A SECOND CASE GROUP WITH ABNORMAL TYROSINE 
CUTOFF SET AT I 500 MG/DL 
Beginning September 1, 2002 the NC Newborn Screening Program changed 
their criteria for abnormal tyrosine from H300 mg/dl to H500 mg/dl. To provide 
information that reflected this change in the “abnormal” criteria, a second case group 
was created from infants born January 1, 2000 through December 31, 2003 who had 
elevated tyrosine of H500 mg/dl.  
For the second case group (elevated tyrosine H500 mg/dl), the number of 
cases was much smaller (n=233), resulting in decreased precision in effect 
estimates. Since results were similar to the main study group, the results are 
presented below in the Tables A2.1 - A2.3 to provide further information, but are not 
discussed separately in the main chapter content.  
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Table A2.1 Adjusted Odds and 95% Confidence Intervals for the Risk of 
Abnormal Tyrosine Screen (I 500 mg/dl) by Risk Factor 
 Risk Factors AOR† 95% CI 
Demographic 
Gender   
 Male 1.0 - 
 Female 1.1 0.8, 1.5 
Race / Ethnicity   
 Non-Hispanic White 1.0 - 
 Non-Hispanic African American 1.6 1.1, 2.4 
 Non-Hispanic Other Race 2.2 1.2, 4.4 
 Hispanic Any Race 2.8 1.7, 4.5 
Small for Gestational Age   
 Not SGA 1.0 - 
 SGA 2.1 1.3, 3.3 
Patient Age at Screen Collection   
 T72 hours 1.0 - 
 >72 hours 3.6 2.1, 6.3 
Multiple Birth   
 Singleton 1.0 - 
 Multiple 1.0 0.6, 1.8 
 
Maternal Characteristics 
Maternal Age   
 Adult Mom (H20 yrs) 1.0 - 
 Teen Mom (<20 yrs) 1.1 0.7, 2.0 
Parity   
 Primipara 1.0 - 
 Multipara 1.5 1.1, 2.3 
n= 2,302, cases= 233, controls=2,069 
†Each risk factor adjusted for other factors in table and gestational age and feeding 
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Table A2.2 Adjusted Odds† and 95% Confidence Intervals for the Risk 
Associated with Type of Feeding on Abnormal Tyrosine Screen (I 500 mg/dl) 
Conditional on Gestational Age 
 Feeding Type AOR 95% CI 
Preterm: Formula, exclusive  23.9 10.8, 52.8 
Breastmilk, exclusive  27.2    12.9, 57.2 
 TPN, exclusive           123.1    53.9, 281.1 
 Combination   35.5    15.4, 82.0 
 
Term: Formula, exclusive      1.0           - 
 Breastmilk, exclusive      2.7    1.3, 5.5 
 TPN, exclusive     11.6    3.6,36.7 
 Combination       3.2    1.4, 7.2 
n= 2,302, cases= 233, controls=2,069 
† Adjusted for gender, race/ethnicity, size-for-gestational-age, multiplicity, maternal age, and parity. 
 
